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ABSTRACT 
John Paul Spence 
 
Nf1-DEFICIENT MICE DISPLAY SOCIAL LEARNING DEFICITS THAT ARE 
RESCUED BY THE DELETION OF PAK1 GENE 
 
Neurofibromatosis type 1 (NF1) is a neurocutaneous disorder that affects 
roughly 1 in 3500 individuals. In addition to physical features (e.g., 
neurofibromas), developmental disorders are also common that can affect 
cognition, learning, attention and social function. The NF1 gene encodes 
neurofibromin, a GTPase activating protein (GAP)-like protein that negatively 
regulates Ras GTPase activation. Mutation at the NF1 locus increases the output 
of MAPK and PI3K signal transduction from the cellular membrane to the 
nucleus. Similar to humans, Nf1+/- mice show spatial learning abnormalities that 
are potentially correlated with increases in GABA-mediated inhibition and deficits 
in long-term potentiation in the hippocampus. Here, we demonstrate for the first 
time that Nf1+/- mice exhibit a selective loss of long-term social learning / memory 
and increased GABAergic inhibition in the basolateral amygdala, a critical brain 
region for regulating social behaviors. Next, utilizing a genetic intercross, we 
show that the co-deletion of p21-activated kinase type 1 (Pak1-/-), which 
positively regulates MAPK activation, restores Nf1+/--dependent MAPK 
hyperactivation in neurons cultured from the frontal cortex. We found that the co-
deletion of Pak1 in Nf1+/- mice (Nf1+/- / Pak1-/-) also restores the deficits in long-
 vii 
 
term social learning / memory seen in Nf1+/- mice and normalizes the increases in 
GABA-mediated inhibition in the BLA, as compared to Nf1+/- mice. Together, 
these findings establish a role for Nf1 and Pak1 genes in the regulation of social 
learning in Nf1-deficient mice. Furthermore, proteomic studies identify 
dysregulation of F-actin and microtubule dynamics in the prefrontal cortex, and 
implicate proteins associated with vesicular release as well as neurite formation 
and outgrowth (e.g., LSAMP, STXBP1, DREB). In the BLA, disintegrin and 
metalloproteinase domain-containing protein 22 (ADAM22) was identified, and 
ADAM22 may play a role in the regulation of AMPA receptors. Finally, due to the 
increased co-occurrence of NF1 and autism, these findings may also have 
important implications for the pathology and treatment of NF1-related social 
deficits and some forms of autism. 
 
Anantha Shekhar, M.D., Ph.D., Chair 
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INTRODUCTION 
A. Background 
While illustrations of neurofibromatosis-like characteristics date to the 
second century and the first clinical description of neurofibromatosis type 1 (NF1) 
is likely that of a man with a plexiform neurofibroma dating back to the sixteenth 
century (Hecht, 1989; Zanca and Zanca, 1980), the term “neurofibroma” was first 
coined in 1882 by the physician Friedrich Daniel von Recklinghausen in his 
landmark report entitled “On multiple cutaneous fibromas and their relationship to 
multiple neuromas”. However, the specific forms of von Recklinghausen‟s 
disease were not clinically differentiated until the late 1970s. In addition to NF1, 
other neurocutaneous disorders include neurofibromatosis type 2, tuberous 
sclerosis, Von-Hipple Lindau syndrome and Sturge-Weber syndrome. NF1 
represents the most frequent among the disorders that were previously defined 
as von Recklinghausen‟s disease (see Ruggieri and Huson, 1999 for review). 
 
1. Epidemiology of NF1 
To date, the current epidemiological data compiled for NF1 has been 
largely generated from Caucasian and Japanese subjects; however, NF1 is 
observed world-wide and does not appear to be influenced by ethnicity (see 
Friedman, 1999 for review). NF1 is caused by mutation in one copy of the NF1 
gene (NF1+/-), and affects roughly 1 in every 3000-4000 individuals world-wide. 
NF1 is a simple autosomal dominant disorder that displays full penetrance in 
adulthood. To date, the homozygous deletion of the NF1 gene (NF1-/-) is has not 
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yet been detected in humans suggesting that NF1-/- genotype is likely lethal 
(Messiaen et al, 2000). Likewise, rodents that encode null mutations in both 
copies of the Nf1 gene (Nf1-/-) die in utero at 12-14 days of gestation due to heart 
malformations (Jacks et al, 1994; Brannan et al, 1994). While most cases of NF1 
can be diagnosed by eight years of age, nearly all cases are diagnosed by age 
20 (DeBella et al, 2000).  
The symptoms of NF1 are variably present between individuals as well as 
within families, and NF1 does not appear to be influenced by sex or race 
(Friedman and Birch, 1997). NF1 is a chronic disorder associated with lifelong 
morbidity and increased mortality. Likely due to the progressive nature of the 
disorder, the life expectancy of an affected individual is significantly lower than 
normal and ranges from 54-62 years of age compared to 70 in the general 
population (Rasmussen et al, 2001).  This high mortality rate has been attributed 
to an increased incidence of brain tumors, malignant cancers as well as 
hypertension and cardiovascular disease (Rasmussen et al, 2001).   
 
2. Physical features of NF1 
Established in 1987 by the National Institute of Health (NIH) Consensus 
Conference on Neurofibromatosis, the diagnostic criteria for NF1 summarize 
common physical features associated with the NF1 phenotype (NIH, 1988). 
Neurofibromas represent the most commonly found NF1-related tumor occurring 
in more than 95% of NF1 patients (see Bader, 1986 for review). Usually seen 
during early adolescence, cutaneous neurofibromas appear as soft, purplish 
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bumps on the skin, while subcutaneous neurofibromas usually appear as 
palpations of the skin (Riccardi, 1980). Dermal and subcutaneous neurofibromas 
are often associated with cosmetic problems, pain, and pruritus (i.e., intense 
itching of the skin; Creange et al, 1999). Plexiform neurofibromas are highly 
vascular encasing major nerves, blood vessels as well as other vital structures 
(Schorry et al, 1997; see Korf, 1999 for review). Therefore, neurofibromas can 
significantly impact the quality of life of NF1 patients leading to significant 
morbidity due to gross disfigurement. In addition, plexiform neurofibromas can 
transform into malignant peripheral nerve sheath tumors (MPNSTs) leading to 
metastasis and premature death (Tucker et al, 2005). 
NF1-affected individuals manifest a wide array of non-malignant physical 
features including café-au-lait spots, skin-fold freckling, optic gliomas, Lisch 
nodules and skeletal malformations (see Ferner et al, 2007 for review). Café-au-
lait spots are frequently observed in NF1 patients (roughly 95%) at early stages 
of development and appear light to dark brown in color (North, 1993). Crowe‟s 
sign or skin-fold freckling are present in roughly 30% of NF1 patients often 
observed under the armpit, in the groin area and around the base of the neck 
(North, 1993). Gliomas are tumors that arise from glial cells and can occur in the 
optic pathways, brainstem and cerebellum of NF1 patients (Creange, 1999). 
Detected in 15-20% of patients, optic pathway gliomas can lead to vision loss 
(Zeid et al, 2006; see Listernick for review). Unique to NF1 patients, Lisch 
nodules are yellow to brown dome-shaped elevations projecting from the surface 
of the iris (Richetta et al, 2004). NF1 patients can also exhibit a variety of skeletal 
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problems including scoliosis, tibial bowing and pseudarthrosis or a false joint 
associated with abnormal skeletal movement (Crawford and Bagamery, 1986). 
Other symptoms are also observed at an increased frequency in 
individuals with NF1. For instance, NF1 patients have an increased risk for 
developing epilepsy with an incidence of 4 to 6%, and epileptic seizures are often 
due to intracranial masses and other cytoarchitectural abnormalities (Vivarelli et 
al, 2003). Cardiovascular disorders are frequently observed in NF1 patients 
including vasculopathy, hypertension, and congenital heart defects (Friedman et 
al, 2002). Phaeochromocytomas or neuroendocrine tumors of glands in the 
adrenal medulla are detected in roughly 2% of NF1 patients, and approximately 
12% of these tumors are malignant (Bausch, 2005).  Macrocephaly is observed 
in 30-50% of patients diagnosed with NF1, and other minor features include short 
stature, angiomas as well as and thoracic abnormalities (Cnossen et al, 1998). 
 
3. Genetics of NF1 pathogenesis 
NF1 is a product of mutation in one copy of the NF1 gene. Using linkage 
analyses, the chromosomal region responsible for NF1 was localized to 
chromosome 17 (Goldgar, 1989; Wallace et al, 1990). Shortly thereafter, the NF1 
locus was mapped to chromosome 17q11.2 by positional cloning (Cawthon et al, 
1990). Utilizing cDNA walking strategies and DNA sequencing, the complete 
coding region of the NF1 transcript was cloned revealing that the NF1 gene 
encompasses over 300 Kb of genomic DNA with 60 exons (Xu et al, 1990; 
Marchuk et al, 1991). The chromosomal region linked to the NF1 gene is 
 5 
 
unstable and prone to rearrangements, and represents a “hot spot” for sporadic 
mutation (Van Roy et al, 2002). Germline mutations in the NF1 gene were 
characterized utilizing DNA and RNA sequencing, and included nonsense, 
frame-shift, missense, and splice mutations as well as in-frame deletions and 
translocations (Messiaen et al, 2000). Accounting for roughly 30% of mutations, 
exons 10a-10c and 37 represent the most common regions for mutation 
(Messiaen et al, 2000). However, specific NF1 variants have not yet been 
correlated with NF1-related features or severity in human studies of association 
(Castle et al, 2003). 
 
4. Biochemistry of neurofibromin 
The NF1 gene encodes the protein product neurofibromin with 2818 
amino acids (Xu et al, 1990; see Gutmann and Collins for review). Neurofibromin 
is a cytoplasmic guanosine triphosphatase (GTPase)-activating protein (GAP)-
like protein that negatively regulates RAS-GTPase activity. The amino acid 
sequence of neurofibromin is highly homologous with mammalian GAP and yeast 
IRA proteins (Xu et al, 1990; Ballester et al, 1990). In yeast, the expression of 
neurofibromin leads to the inhibition of human RAS proteins that are 
coexpressed, and the deletion of neurofibromin is associated with increased RAS 
GTPase-stimulating activity (Ballester et al, 1990). Furthermore, a fragment of 
NF1 cDNA encoding the GAP-related domain (NF1-GRD) was expressed in vitro 
and tested for its effects on RAS-GTPase activity, and found that the NF1-GRD, 
a region located between amino acids 1125 and 1537, is primarily responsible for 
the inactivation of RAS-GTPase activity (Martin et al, 1990). Kinetic 
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measurements indicate that neurofibromin regulates RAS-GTPase activity, 
particularly at low concentrations (Martin et al, 1990).  Characterizing tumor cells 
isolated from NF1 patients, in vitro and in vivo studies found that neurofibromin 
negatively regulates RAS-GTPase activity, and demonstrate a “positive” growth 
role for RAS activity in NF1 tumorigensis (DeClue et al, 1992; Downward, 1992; 
Upadhyaya et al, 1997).  
Due to its role as a negative regulator of RAS activation, neurofibromin 
acts as a key regulator in signal transduction from the cell membrane to the 
nucleus (see Le and Parada, 2007 for review; Figure 1). RAS is recruited when a 
growth factor(s) binds to a receptor on the extracellular matrix of the cell 
membrane, and RAS-GDP is then converted to RAS-GTP through its interaction 
with the GRB2 adapter and guanine nucleotide exchange factor SOS (see 
Margolis and Skolnik for review). The active form of RAS or RAS-GTP is, in part, 
responsible for the propagation of the classical RAS-RAF-MEK-ERK or MAPK. 
RAS-GTP binds to RAF serine/threonine kinase (RAF; Stokoe et al, 1994), and 
activated RAF leads to the phosphorylation and activation of MAP kinase/ERK 
kinase (MEK; Kyriakis et al, 1992). In turn, MEK (active form) phosphorylates and 
activates members of the extracellular signal-regulated kinase (ERK) family 
(Crews and Erikson, 1993). Activated ERK then phosphorylates various targets 
including other kinases as well as transcription factors.  
In addition to the MAPK pathway, the active form of RAS or RAS-GTP 
propagates the phosphotidylinositol 3-kinase or PI3K cascades. RAS-GTP binds 
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Figure 1. Neurofibromin is a key regulator of RAS and adenylyl cyclase 
signal transduction from the cell membrane to the nucleus. Neurofibromin, a 
cytoplasmic GAP-like protein, negatively regulates RAS activation by 
accelerating the conversion of RAS-GTP to RAS-GDP and increasing RAS signal 
transduction. The RAS-GTP activates both PI3K and the classical MAPK 
pathway propagating complex interactions of cellular signaling pathways that 
regulate cellular functions. Neurofibromin also binds to microtubules, and 
interacts with adenylyl cyclase to decrease cAMP levels in the central nervous 
system. Thereby, neurofibromin represents a key node in the regulation of 
multiple cellular functions. 
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to and activates the p110 catalytic subunit of PI3K, thereby, resulting in 
increased activity of lipid kinase (Kodaki et al, 1994). PI3K activation leads to the 
activation of downstream effectors including RAC (rho family) and RAL GDP-
dissociation stimulator (RAL-GDS) (Stephens et al, 1996; Welch et al, 2003). 
Furthermore, the activated PI3K also binds to and phosphorylates protein kinase 
B (AKT), and AKT (active form) inactivates the TSC1-TSC2 complex and 
activates TOR or serine/threonine kinase target of rapamycin (Johannessen et al, 
2005). Additionally, neurofibromin binds to adenylyl cyclase (AC) and negatively 
regulates cyclic AMP (cAMP) levels in the CNS in mice (Tong et al, 2002; Brown 
et al, 2010). Neurofibromin has been shown to associate with microtubules (Xu 
and Gutmann, 1997).  
Together, these findings demonstrate that neurofibromin functions as a 
modulatory protein in the cell by accelerating the hydrolysis of RAS-GTP (its 
active form) to RAS-guanosine diphosphate (GDP), its inactive form (Ballester et 
al, 1990; Martin et al, 1990; DeClue et al, 1992). Thereby, neurofibromin reduces 
the strength and duration of RAS signal transduction. Unltimately, the Nf1+/- 
genotype results in dysregulation of MAPK and PI3K signal transduction and 
decreases in cAMP levels in the CNS. 
 
5. Pak1 regulation of Nf1-dependent pathways 
McDaniel et al (2008) demonstrates that the co-deletion of Pak1 in Nf1+/- 
mice restores MAPK hyperactivation and abnormalities in cellular proliferation 
and migration that are associated with the Nf1+/- genotype (Figure 2).  PAK1 is a 
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Figure 2. Pak1 inactivation corrects gain-in-function phenotypes seen in 
Nf1 haploinsufficient mast cells. The illustration depicts a hypothetical 
mechanism(s) explaining how Pak1 may interact with MAPK to restore 
abnormalities in cellular proliferation and migration seen in Nf1 haploinsufficient 
mast cells.  
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down-stream effector of the PI3K pathway, specifically Rac, and is abundantly 
expressed in the central nervous system (see Arias-Romero and Chernoff, 2008 
for review). In humans, PAK1 gene maps to 11q13-q14 (Bekri et al, 1997). PAK1 
encodes a protein product consisting of 545 amino acids that is 98% identical to 
mouse PAK1 and 52% identical to yeast Ste20 (Brown et al, 1996). PAK1 is 
enriched in neurons and oligodendrocytes and localized to pinocytic vesicles and 
cortical actin structures (Dharmawardhane et al, 1997). PAK1 is a member of a 
family of serine/threonine kinases and is highly homologous to PAK2 (γ-PAK) 
and PAK3 (β-PAK) (Brown et al, 1996).  
PAK1 is a downstream effector regulated by the Rho family of GTPases 
that include RAC, RHO, and CDC42 (Manser et al, 1995; see Bishop and Hall, 
2000 for review). The members of the Rho family of GTPases mediate diverse 
cellular functions that include cytoskeletal dynamics, vesicular transport, gene 
expression, and oxidant generation (see Nikolic, 2008 for review). Studies have 
established that the catalytic region in PAK1 (i.e., p21-binding domain or PBD) is 
located between amino acids 67 and 113 (Lei et al, 2000). To become 
biologically active, PAK1 and other PAK proteins interact with the active form or 
GTP-bound RAC or CDC42 (Manser et al, 1995). In its active state, the PBD of 
PAK1 dramatically increases the phosphotransferase activity of PAK1 on myelin 
basic protein (Knaus et al, 1995). In addition to the PBD in PAK1, an overlapping 
inhibitory switch regulates basal kinase activity, and amino acid domains in the 
N-terminus of PAK1 can bind to adapter proteins including NCK, GRB2, amng 
others (Bokoch et al, 1996). PAK1 can also be activated through mechanisms 
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that are GTPase-independent including lipid binding as well as 
autophosphorylation (Bokoch et al, 1998). 
PAK1 has been shown to interact with a variety of downstream targets. 
For example, PAK1 mediates cytoskeletal dynamics through the regulation of 
actin organization and polymerizes filamentous actin into orthogonal networks at 
the membrane (Vadlamudi et al, 2002). Furthermore, PAK1 regulates LIM kinase 
activity, leading to the destabilization cofilin and the inactivation and aggregation 
of F-actin fibers (Ishibashi, 2008). The overexpression of Pak1 leads to increases 
in cellular motility and actin polymerization, while the expression of dominant 
negative Pak1 results in decreases in migration and organized actin structures 
(Sells et al, 1999). Thereby, PAK1 regulates cellular motility driven by the 
assembly and disassembly of actin filaments. PAK1 also mediates microtubule 
dynamics through the phosphorylation and inactivation of the microtubule-
destabilizing protein stathmin (Daub et al, 2001). 
More recent studies demonstrate that PAK1 can positively regulate MAPK 
activation. PAK1 has been shown to activate RAF-1 kinase by directly binding to 
and phosphorylating Ser338 (Zang et al, 2002). Additionally, PAK1 directly binds 
to and phosphorylates Ser298 in MEK1, leading to increased RAF-1 activity for 
Ser217/221 as well as increased MEK activation (Coles et al, 2002). Gene 
silencing of Pak1 by small interfering RNA (siRNA) in cultured cells leads to 
significant decreases in ERK activation, and these decreases are associated with 
lower levels of activation in both RAF and MEK (Beeser et al, 2005). By binding 
to Ser338 on RAF-1 and Ser298 on MEK1, PAK1 increases the efficiency of ERK 
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for low-level stimuli, ultimately increasing the levels of ERK activation (Park et al, 
2007).  
Studies initially identified the existence of crosstalk between PI3K and 
MAPK, and implicated the PI3K downstream target RAC2 in the regulation of 
ERK1/2 activation (Ingram et al, 2001). For example, the genetic deletion of Rac 
restores MAPK hyperactivation associated with Nf1+/- genotype in mast cells 
(Ingram et al, 2001). These findings implicated Nf1 haploinsufficiency in 
increased in mast cell proliferation, survival, and colony formation in response to 
the activation of receptor tyrosine kinase (RTK) c-kit by stem cell factor (SCF). 
SCF is a glycoprotein that is both soluble and membrane-bound, and acts as the 
ligand of the transmembrane receptor tyrosine kinase (RTK) c-kit (Besmer et al 
1986). SCF/c-kit signal transduction is involved in the regulation multiple cellular 
functions including growth and development (Saito et al, 1994), cellular 
proliferation (Yee et al, 1994), cell survival (Iemura et al, 1994), and inflamatory 
response (see Reber et al, 2006 for review).  
In addition to the periphery, SCF and c-kit receptor are abundantly 
expressed in the CNS of mice during early stages of development and in 
adulthood (Zhang and Fedoroff, 1997), and has been implicated in neural tube 
organization during embryonic development (Keshet et al, 1991). Similar to the 
inactivation of RAC2, McDaniel et al (2008) found that the inactivation of Pak1 in 
Nf1 haploinsufficient mast cells leads to the correction of in vitro and in vivo gain-
in-function phenotypes that are mediated by SCF/c-kit signal transduction (see 
Figure 2). Based on these findings, the same genetic intercross (Nf1+/- / Pak1-/-) 
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method was implemented in our experimental design in an attempt to restore the 
disruptions in MAPK signaling and learning abnormalities associated with the 
Nf1+/- genotype. 
 
6. NF1 features associated with disruptions in higher CNS functions 
While physical abnormalities represent the “hallmark” characteristics of 
NF1, the heterozygous NF1 gene deletion also elicits significant effects on higher 
CNS function. When NF1 patients were assessed utilizing neuropsychological 
batteries, 80-90% of affected individuals show significant impairments including 
lower academic achievement, learning disabilities, attention, and social function 
(Hofman et al, 1994; North et al, 1997; Dilts et al, 1996; Brewer et al, 1997; 
Johnson et al, 1999; Kayl and Moore 2000; Noll et al, 2007). Similar to the 
physical manifestations associated with NF1, these CNS-related features exhibit 
a high level of variability between individuals, and do not appear to be correlated 
with sex, race or disease severity (North et al, 1995). Furthermore, these 
features also are independent of tumor predisposition (Moore et al, 1994). 
While early studies report a high frequency of mental retardation or an IQ 
less than 70 (Samuelsson and Riccardi, 1989), more recent findings utilizing a 
battery of cognitive assessments suggest that the rate of mental retardation in 
the NF1 population is only slightly higher (4-10%) than the general population 
(Ferner et al, 1996). However, the average IQ is significantly lower than normal 
(around 90) in NF1-affected individuals (Ozonoff, 1999). Multiple studies have 
examined verbal and performance IQ in NF1 patients, and these studies indicate 
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that the heterozygous deletion of NF1 (NF1+/-) is not selective, but impacts both 
verbal and nonverbal aspects of cognition (North et al, 1997).  
NF1 patients also exhibit learning disabilities associated with both visual-
spatial and verbal aspects of learning, affecting roughly 30-65% of NF1-affected 
individuals (see Rosser and Packer, 2003 for review). Visual-spatial deficits are 
most often seen in NF1 patients, as measured by the Judgement of Line 
Orientation task (Hofman et al, 1994). For example, cognitive and 
neuropsychological batteries found that NF1 patients show impairments in spatial 
memory (Varnhagen et al, 1988), visual-motor integration (Dilts et al, 1996), 
visual-spatial skills, and mathematics (Eliason, 1986; Varnhagen et al, 1988; 
North, 1993). Furthermore, tests of academic acheivement also found significant 
impairment in spelling, reading and language skills (Dilts et al, 1996; Cutting et 
al, 2000).  
Attention problems are observed in roughly 30-50% of NF1 children and 
adolescents (Keyhan et al, 2006; Koth et al, 2000; Mautner et al, 2002). As 
compared to controls, NF1 patients display significant deficits in attention 
including problems with concentration, attention, and hyperactivity (Eliason, 
1986; Eliason, 1988; Coude et al, 2007). It has been suggested that these 
problems with attention may contribute to learning disabilities and lower 
academic achievement seen in the NF1 children (Brewer et al, 1997). A meta-
analysis of 152 studies found that 75% of children with learning abnormalities 
also show problems with social skills, as compared to their peers (Kavale and 
Forness, 1996). Furthermore, psychological assessments found that the 
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presence of learning disabilities and attention problems were correlated with 
deficits in social skills, social competence, and other social problems (Barton and 
North, 2004).  
NF1 patients manifest significant problems with social function compared 
to their unaffected siblings affecting roughly 50% of NF1-affected individuals. For 
example, NF1 children are often socially withdrawn, and show difficulty forming 
friendships and have fewer friends than their peers (Dilts et al, 1996, Johnson et 
al, 1999; Barton and North, 2004; Noll et al, 2007). In addition, NF1 children often 
show problems with social perception in that they inappropriately perceive and 
interpret social cues (i.e. facial expressions, body gestures, and tone of voice) 
(Eliason, 1986). Related to these problems with social function, NF1 shows a 
dramatically increased frequency in autistic patients with an estimated 
prevalence of 1.2% in autistic subjects (Martin et al, 2007), and human genetic 
studies found that the NF1 locus is linked to autism (IMGSAC, 2001). However, 
the prevalence of autism in the NF1 population has not yet been determined, and 
the relationship between NF1 and autism is not clearly defined in the literature. 
NF1 patients also display more emotional problems relative to their 
unaffected siblings and the general population (Johnson et al, 1999). For 
instance, Samuelsson and Riccardi (1989) found that 33% of NF1 patients 
showed increased rates of mental illness with the most commonly occurring 
psychiatric diagnoses being depression and anxiety. Another study found that 
roughly one-third of the NF1 subjects fulfilled the criteria for a psychiatric 
disorder, and diagnosed 21% of the NF1 cohort with the mood disorder 
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dysthymia (Zoller and Rembeck, 1999). Similarly, Belzeaux and Lançon (2006) 
observed mental illness in 33% of NF1 patients with dysthymia as the most 
frequent diagnosis (21% of patients). A higher prevalence of depressive mood 
(7%), anxiety (1-6%), and personality (3%) disorders were also observed, and 
the risk of suicide was four times greater than in the general population 
(Belzeaux and Lançon, 2006). Together, these findings indicate that anxiety and 
mood disorders (i.e., depression, dysthymia) are observed at a modestly higher 
frequency in NF1 patients.  
 
7. Mouse models of NF1 
Homologous recombination strategies were utilized to disrupt Nf1, the 
murine homolog of NF1, in an attempt to create an animal model of 
neurofibromatosis (Jacks et al, 1994; Brannan et al, 1994). In mice, the Nf1 locus 
is highly conserved encoding an amino acid sequence that is 98% identical to 
human neurofibromin (Bernards et al, 1993). Similar to humans, the homozygous 
deletion of Nf1 gene is lethal in mice. Nf1-/- mice die in utero at 12-14 days of 
gestation due to heart malformations (Jacks et al, 1994; Brannan et al, 1994). 
Heterozygous mice were developed that carry a null mutation at one copy of the 
Nf1 locus (Nf1+/-). While these Nf1+/- mice do not develop several features 
associated with the NF1 phenotype, Nf1+/- mice do show increased rates of 
myeloid leukemia and phaeochromocytomas or tumors of the neural crest-
derived adrenal medulla (Jacks et al, 1994). Thus, other mechanisms also 
contribute to Nf1+/--related tumorigenesis including the inactivation of a second 
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allele, gene x gene interactions, NF1 hapolinsufficiency, and environmental 
factors.  
The NF1 gene functions as a classic tumor suppressor gene (Colman et 
al, 1995). In chimeric mice partially composed of Nf1-/- cells, the complete loss of 
Nf1 gene leads to the development of neurofibromas (Chichowski et al, 1999).  
Furthermore, mice that have mutations in both Nf1 and p53 genes develop 
malignant peripheral nerve sheath tumors (MPNSTs), soft tissue sarcomas and 
abnormalities in neural crest formation, indicating that the development of 
malignant tumors can also result from gene x gene interactions (Chichowski et al, 
1999; Vogel et al, 1999). By intercrossing Nf1+/- mice with c-kit mutant mice, 
Ingram et al (2000) demonstrates that Nf1 haploinsufficiency leads to enhanced 
MAPK activity and increases in SCF-mediated mast cell proliferation, survival, 
and colony formation. Therefore, Nf1 gene dosing effects alter the interactions 
between mast cells, Schwann cells, fibroblasts, and endothelial cells contributing 
to the tumor microenvironment and tumorigenesis (see Staser et al, 2010 for 
review).  
In addition to the periphery, neurofibromin is abundantly expressed in the 
rodent CNS, and immunostaining of tissue sections localized neurofibromin 
expression to neurons, oligodendrocytes, and nonmyelinating Schwann cells 
(Daston et al, 1992). In the rat brain, neurofibromin is most abundantly expressed 
in large projection neurons including cortical and hippocampal pyramidal cells as 
well as cerebellar Purkinje cells (Nordlund et al, 1993). Neurofibromin is present 
in both cell bodies and axons, and is highly enriched in dendrites and associates 
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with smooth vesiculotubular elements, cisternal stacks as well as multivesicular 
bodies (Nordlund et al, 1993). Neurofibromin is not abundantly expressed in the 
plasma membrane, nucleus, nuclear envelope, Golgi apparatus, mitochondria, or 
rough endoplasmic reticulum (Nordlund et al, 1993).  
Similar to humans NF1 patients, it has been well-established that Nf1+/- 
mice show spatial learning deficits, as measured by the Morris water maze (Silva 
et al, 1997). Costa et al (2002) found that Nf1+/− mice also display increases in 
inhibitory postsynaptic potentials (IPSPs) in cornu Ammon 1 (CA1) pyramidal 
cells of hippocampal slices (Costa et al, 2002). This increase in IPSPs is 
consistent with postsynaptic changes that decrease the likelihood of postsynaptic 
action potentials in CA1 pyramidal cells in the hippocampus. Nf1+/- mice also 
exhibit no differences in long-term potentiation (LTP), whereas LTP induced at 
the stimulation strength of 60mA is larger than LTP induced at 35mA in WT mice 
(Costa et al, 2002). For a review of IPSPs, refer to Functions of the basolateral 
amygdala section on page 28, and for a review of LTP mechanisms, refer to 
Processes involved in learning and memory section on page 21. 
Pharmacological and genetic manipulations in Nf1+/− mice that restore 
RAS signaling can reverse the spatial learning abnormalities as well as the 
increases in IPSPs and deficits in LTP seen in CA1 pyramidal cells of 
hippocampal slices (Costa et al, 2002). For instance, mice heterozygous for 
mutations in both Nf1 and K-ras genes (Nf1+/- / K-ras+/-) show similar 
performance on the hidden water maze task as WT mice, and display restored 
IPSPs and LTP (Costa et al, 2002). These deficits can also be restored in the 
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Nf1+/- mutant mice by administering farnesyl-transferase inhibitors. Farnesyl-
transferase inhibitors block the post-translational farnesylation of RAS protein, a 
process necessary for RAS activation (Costa et al, 2002; Li et al, 2005). 
Therefore, these findings demonstrate that Nf1+/--mediated deficits in spatial 
learning and associated abnormalities in IPSPs and LTP are mediated by RAS-
dependent processes (see Costa and Silva, 2003 for review).  
To further characterize the mechanism(s) underlying the spatial learning 
deficits seen in Nf1+/- mutant mice, Cui et al (2008) generated heterozygous Cre-
mediated deletions of the Nf1 gene in various cell types in the brain. The 
resulting mice expressed deletions of Nf1 in the following cell types: both 
excitatory and inhibitory neurons (Nf1synI; with synapsin I-Cre), forebrain 
GABAergic neurons (Nf1Dlx5/6; with Dlx5/6-cre), forebrain pyramidal neurons 
(Nf1aCaMKII; with aCaMKII-Cre), and most astrocytes (Nf1GFAP; with GFAP-Cre). 
Cui et al (2008) found that only synapsin I and Dlx5/6 Cre-mediated deletions of 
the Nf1 gene result in spatial learning deficits mice, thereby, implicating inhibitory 
interneurons in Nf1-related spatial learning deficits. These inhibitory interneurons 
branch locally and innervate other neurons, thereby, decreasing their likelihood 
of a postsynaptic action potential. 
Using electrophysiological studies, Cui et al (2008) further demonstrates 
that these Cre-mediated deletions of Nf1 gene result in increased miniature 
inhibitory postsynaptic current (mIPSC) frequency under periods of high-
frequency stimulation (12.5 mM KCl) in CA1 pyramidal cells of hippocampal 
slices. Similar to previous findings (Costa et al, 2002), these Cre-mediated 
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deletions of Nf1 gene also lead to deficits in LTP (Cui et al, 2008). Additionally, 
the pharmacological inhibition of MAPK using MEK inhibitors can reverse the 
increases in mIPSC frequency seen in Nf1+/- mice suggesting that these 
increases in mIPSC frequency are mediated by a MAPK-dependent mechanism 
(Cui et al, 2008).  
In a separate study using a different animal model of NF1, Costa et al 
(2001) characterized the effect(s) of a spice variant of the Nf1 gene in mice. The 
Nf1 gene encodes mRNA with two alternative splices (Danglot et al, 1995). Exon 
23a represents an alternatively spliced region of the Nf1 gene that encodes 21 
amino acids within the NF1-GRD domain (Martin et al, 1990). The type 1 isoform 
of NF1 excludes exon 23a, while the type 2 isoform includes this region. 
Compared to the type 1 isoform, the type 2 isoform has lower GAP activity, but 
greater affinity for Ras (Viskochil, 1999). Like the Nf1+/- mice, mice with a 
homozygous deletion of exon 23a in Nf1 gene also exhibit impairments in spatial 
learning, as measured by the Morris water maze (Costa et al, 2001). Unlike the 
Nf1+/- mice, mice with the homozygous deletion of exon 23a are viable and do not 
show an increased tumor predisposition (Costa et al, 2001). Similar to the Nf1+/- 
mice, the Nf123a-/- exhibit increases in IPSPs and abnormal LTP in the 
hippocampus that can be rescued by decreasing RAS function (Costa et al, 
2001). These findings further implicate the NF1-GRD in the spatial learning 
deficits and abnormalities in IPSPs and LTP associated with the Nf1 gene 
deletion in mice. 
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8. Processes involved in learning and memory 
Learning and memory involves complex processes and the integration of 
multiple structures in the CNS (see Purves et al, 2004 for review). Encoding 
represents the initial process whereby sensory information induces cellular and 
molecular changes to neurons. Sensory inputs can generate either short-term 
memories that only last for seconds to minutes or long-term memories that can 
last for days or even indefinitely. During consolidation these cellular and 
molecular changes lead to persistent alterations in “synaptic strength” within 
neuronal circuits (i.e., memory storage and retention). Memories are encoded by 
modifications of synaptic strength in the CNS, and these changes to sypapses 
are defined as synaptic plasticity. 
 Long-term potentiation (LTP) is a cellular mechanism that is thought to 
contribute to memory storage underlying synaptic plasticity (see Tronson and 
Taylor, 2007 for review). In hippocampal slices, LTP results from a brief, high-
frequency train of stimuli to the same axon (i.e., Schaffer collaterals) leading to a 
long-lasting enhancement in excitatory postsynaptic potentials (EPSPs) in CA1 
neurons in the hippocampus (see Cooke and Bliss, 2006 for review). 
Mechanistically, LTP is triggered by the expolsion of the Mg2+ block from the 
NMDA channel in the postsynaptic neuron. If the postsynaptic neuron is 
sufficiently depolarized, Ca2+ ions freely enter the NMDA channel activating 
postsynaptic protein kinases, and these protein kinases insert new AMPA 
receptors into the postsynaptic spine increasing the sensitivity to glutamate (i.e., 
the major excitatory neurotransmitter in the brain), and ultimately defining the 
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number, size and shape of dendritic spines (see Bliss and Collingridge, 1993 for 
review).  
Memory recall refers to the ability to retrieve stored information previously 
encoded from past experience. Memory has been categorized into two main 
constructs including declarative and procedural memories (see Fernald 1997 for 
review). Declarative memory is recalled by a deliberate and conscious effort, 
while non-declarative memory is retrieved automatically with no deliberate or 
conscious effort (e.g., procedural memory). Encoding new declarative memories 
requires an intact hippocampus and associated midline diencephalic and medial 
temporal lobes (Corkin, 1984; Corkin et al, 1997). In contrast, procedural memory 
is largely regulated by the premotor cortex, basal ganglia and cerebellum. 
Thereby, learning and memory processes enable an organism to process past 
experiences enabling a more effective adaptive response to environment stimuli.  
Learning and memory requires morphological changes at the synapse, 
including the formation of new synapses or the strengthening of existing 
synapses (see Cooke and Bliss for review). In recent years, accumulating 
evidence has demonstrated that the MAPK signaling pathway plays an important 
role in the regulation of learning and memory (see Peng et al, 2010 for review). 
Studies have identified increases in ERK activation during long-term memory 
encoding and consolidation following training (Feld et al, 2005). In addition, 
increased ERK activation was detected for training in the Morris water maze 
(Blum et al, 1999) and following contextual fear conditioning learning (Atkins et 
al, 1998; Bozon et al, 2003). Merino and Maren (2006) measured the effects of a 
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Ras antagonist administered in the BLA on fear conditioning, and found that 
MAPK is required for the acquisition of long-term fear. Therefore, MAPK 
signaling is thought to play an important role in regulating memory encoding (see 
Giovannini for review). 
 
9. Neural basis of social behavior 
In humans, social behavior is mediated by complex processes involving 
multiple brain regions functioning in concert to coordinate a response to a social 
stimulus (Figure 3; see Insel and Fernald, 2004 for review). Cortical regions 
perceive socially relevant stimuli and communicate this information to the 
amygdala, orbitofrontal cortex, anterior and posterior cingulate cortices, and 
somatosensory-related cortices (see Adolphs, 2009 for review). These brain 
regions define the stimuli based on motivation or reward, emotions, and 
cognition, and then communicate this information to motor and emotional outputs 
(see Adolphs et al, 2002a-b for review). Therefore, the neural substrates that 
mediate social behavior consist of complex, integrated circuits within and 
between brain regions that perceive social stimuli (e.g., olfactory, visual, 
auditory), define their emotional valence (prefrontal cortex, amygdala, temporal 
cortex), evaluate social motivations (ventral tegmental area, nucleus accumbens, 
ventral pallidum), and ultimately provides this information to the appropriate brain 
regions that determine an adaptive social response (see Insel and Fernald, 
2004). 
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Figure 3. A simplified model of processes involved in social learning and 
memory. The figure above illustrates a theoretical model of the processes and 
brain regions involved in social learning and memory. Sensory information is 
initially processed by the accessory olfactory bulb, fusiform area or superior 
temporal gyrus. This sensory information is then defined by complex integrated 
networks in the CNS. Emotional valence is determined by projections to the 
prefrontal cortex, amygdala and temoporal cortex. Social motivation is processed 
by the VTA, nucleus accumbens, and ventral pallidum. These brain regions 
integrate sensory information, determine the appropriate emotional and/or 
motivational relevance, and then provide the information to the other brain 
regions affecting social behavior. AOB - accessory olfactory bulb; FFA - fusiform 
area; STF - superior temporal gyrus; VTA - ventral tegmental area 
Social cues (input) AOB (olfaction), FFA (vision), STG (auditory)
Emotional valence Prefrontal cortex, amygdala, temporal cortex
Social motivation VTA, nucleus accumbens, ventral pallidum
Social behavior (output) Hypothalamus, motor and autonomic pathways
Adapted from Insel and Fernald, Annu Rev Neurosci (2004)
Information Processing in the Social Brain
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Facial recognition represents a core component of social behavior and 
social learning in humans. Prosopagnosia or “face blindness” is particularly 
relevant to understanding the neurosubstrates involved in social learning due to 
its selective impairment of facial recognition. In addition to other brain regions, 
functional imaging studies and lesion studies suggest that facial recognition is 
regulated by the frontal cortex (Hornak et al, 1996) and the amygdala (LeDoux, 
1992; Luo et al, 2007). For instance, a functional imaging study that measured 
delayed matching to emotional expressions on human faces found that the 
prefrontal cortex and amygdala are recruited during working memory for social 
cues (LoPresti et al, 2009). Utilizing functional imaging studies and tractwise 
analyses, a recent study measured the effects of damage to the two tracts in the 
human CNS on facial recognition (Philippi, 2009). The findings demonstrate that 
damage to the tract connecting the occipital cortex with the anterior temporal 
lobe and amygdala, or damage to the tract connecting the occipital cortex, the 
temporal cortex, and the orbitofrontal cortex leads to impairment in facial 
recognition (Philippi, 2009). Therefore, these findings implicate the prefrontal-
amygdala circuit in facial recognition processing (Philippi, 2009). 
The prefrontal-amygdala circuit defines a primary processing center for 
emotional aspects of social response, and its dysregulation can have profound 
effects on social function in humans (see Blair, 2008 for review). For example, 
individuals with damage to the frontal cortex can show blunted affect, impaired 
goal-directed behavior and inappropriate social conduct (Barrash et al, 2000). 
Additionally, lesion studes demonstrate that damage to the frontal cortex impairs 
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the ability to react to emotionally charged pictures (Damasio et al, 1990). 
Similarly, damage to the amygdala leads to impairment in the facial recognition 
that are associated with emotions (Adolphs et al, 2003). While amygdala-
dependent learning is often associated with fearful or negative emotional 
response, the amygdala also actively processes cues associated with a positive 
emotional valence (see Bachevalier and Malkova for review). For instance, the 
amygdala is activated when a child is presented with his mother‟s face (Todd et 
al, 2010). The amygdala is also essential for the regulation of social perception in 
that humans with amygdala lesions lack any sense of personal space during 
face-to-face interactions (Kennedy et al, 2009; Todd et al, 2009). Together, these 
findings demonstrate that the prefrontal-amygdala circuit is critical for processing 
cues during social encounters.  
 
10. Social behavior and social learning in mice 
In the natural environment, social behavior in mice is necessary for 
reproduction, territoriality, and the establishment of dominance. Dyadic social 
interactions represent a core component of social behaviors, and these 
interactions are defined by both innate and learned responses to social cues. In a 
laboratory setting, social interaction can be characterized by measuring the 
approach verses avoidance of a mouse toward a conspecific (Brodkin et al, 
2004; Sankoorikal et al, 2006; Crawley et al, 2007). Social approach verses 
social avoidance is thought to be a product of multiple, sometimes opposing 
motivations that drive social behavior in mice (Sankoorikal et al, 2006). For 
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example, motivations that lead to social approach might include social 
investigation, play, reproduction, or offensive aggression, while social avoidance 
can potentially be a product of generalized anxiety, social anxiety, or fear of the 
other mouse.  
In addition to innate response, mouse behavior is influenced by the ability 
to learn and then remember cues associated with individual conspecifics 
(Crawley et al, 2007; see Silverman et al, 2010 for review). Behavioral tests have 
been designed to test various aspects associated with social learning and 
memory utilizing approach and avoidance paradigms (Crawley et al, 2007). In the 
present dissertation, the amount of time the “test” mice spent sniffing (i.e., nose 
pointed toward cage and within one inch of cage) novel verses familiar 
conspecifics were determined in order to generate a quantitative measure of 
social approach, as defined by “preference for social novelty” (Nadler et al, 2004; 
Crawley et al, 2007). Thereby, short-term and long-term social learning / memory 
in mice were assessed based on their ability to discriminate between social cues 
associated with different conspecifics (Crawley et al, 2007). While three main 
stages contribute to memory formation including acquisition, consolidation, and 
retrieval (see Purves et al, 2004 for review), learning and memory is presented 
as a single construct throughout this body of work. 
Social learning and the motivations that underlie social approach and 
avoidance to a conspecific are mediated by multiple brain regions (see Figure 3). 
However, these brain regions do not process social information exclusively, but 
process sensory information that is independent of a social context. The 
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amygdala has been implicated in both anxiety and fear-based learning (see 
LeDoux, 1993 for review). For instance, both electrical and pharamacological 
stimulation of the amygdala induces an enhanced cardiovascular response and 
behavioral arousal consistent with a fight-or-flight response (Kapp et al, 1982; 
Maskati and Zbrozyma, 1989). Likewise, when presented with a conspecific, 
social avoidance behavior can reflect anxiety or fear of the other mouse. By 
selectively targeting the basolateral amygdala (BLA) using pharmacological 
manipulation, previous studies demonstrate that the amygdala also regulates 
social aspects of anxiety and fear-based learning (Sanders and Shekhar, 1996; 
Sajdyk and Shekhar, 2000; Shekhar et al, 2001; Sajdyk et al, 2008). Thereby, 
learning and memory processes and brain regions that mediate social memory 
overlap with those that mediate anxiety and fear memory. 
 
11. Functions of the basolateral amygdala 
NF1 is associated with a higher incidence of learning disabilities, attention 
deficits, social problems and psychiatric disorders, including anxiety and 
depression (see NF1 features associated with disruptions in higher CNS 
functions section for review). Due to its role in regulation and processing of 
emotional information, the amygdala network represents a brain region of 
particular interest to these NF1-related features (see McGaugh, 2002 for review). 
The amgydala is composed of multiple sub-nuclei that work in concert to 
coordinate a response to emotional information (Figure 4). These sub-nuclei 
include the basolateral (BLA), lateral (LA), medial (ME) and central (CE). The LA  
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Figure 4. A simplified schematic representation of the neurochemical 
circuitry within the BLA and its connectivity to the PFC involved in the 
regulation of emotional response. Glutamatergic projection neurons within the 
BLA are regulated by excitatory input (+) from the LA and other cortical regions 
(direct sensory information) and by inhibitory input (-) from local inhibitory 
interneurons. These inhibitory neurons process input from the PFC regarding the 
predicted ability to cope with sensory inputs. Additionally, serotonin from the 
dorsal raphe nucleus and norepinephrine from the locus coeruleus provide 
modulatory input to the BLA that mediates the balance of the stimulus and coping 
inputs from these cortical regions. Therefore, the BLA functions utilizing multiple 
feedback loops containing many neurotransmitters (i.e., Glu, GABA, 5-HT, NE) 
and neuropeptides (i.e., CB, CCK, CR, NPY, PV, SOM, VIP) to regulate 
cardiovascular, autonomic and behavioral response. 5-HT - serotonin; BLA, 
basolateral amygdala; CB - calbindin; CCK -  cholecystokinin; CeA - central 
nuclelus of the amygdala; CR - calretinin; DRN - dorsal raphe nucleus; GABA - 
gamma-aminobutyric acid; Glu - glutamate; LA - lateral amygdala; LC - locus 
coeruleus; ME - medial nucleus of the amygdala; NE, norepinephrine; NPY - 
neuropeptide Y; PFC - prefrontal cortex; PV - parvalbumin; SOM, somatostatin; 
VIP - vasoactive intestinal peptide 
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and BLA sub-nuclei are the major sites of afferent inputs, while the ME and CE 
are the major efferent areas (Amaral et al, 1992). The BLA is hypothesized to 
play a central role in the mediation of amygdala-dependent response integrating 
a wide range of sensory information, determining the appropriate emotional 
valence, and then providing the information to the relevant brain regions 
(LeDoux, 1993).  
The BLA is comprised of large spiny pyramidal (i.e., glutamatergic 
projection neurons) and non-pyramidal neurons while the non-pyramidal cells are 
predominantly GABAergic (McDonald, 1984). Similar to cortical structures, these 
glutamatergic projection neurons in the BLA are tonically inhibited by local 
GABAergic interneurons (Rainnie et al, 1991a,b). In the BLA, glutamatergic 
projection neurons are regulated by excitatory inputs from cortical and subcortical 
centers (largely sensory information) and inhibitory inputs from local GABAergic 
interneurons (Truitt et al, 2007). Glutamate and GABA are the main exicitatory 
and inhibitory neurotransmitters in the CNS, respectively. In addition to glutamate 
and GABA, other neurotransmitters are localized to the BLA including serotonin 
from the dorsal raphe (Norita and Kawamura, 1980) and norepinephrine from the 
locus coeruleus (Fallon et al, 1978). Other minor neurotransmitters include 
epinephrine, dopamine, and acetylcholine.  
Neuropeptides are also abundantly expressed in the basolateral 
amygdala. The most common neuropeptides include somatostatin (SOM; Amaral 
et al, 1989), neuropeptide Y (NPY; Gustafson et al, 1986), and cholecystokinin 
(CCK; Kritzer et al, 1988). In the basolateral and lateral amygdala, SOM and 
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NPY are extensively colocalized with GABA (McDonald and Pearson, 1989), and 
CCK is also found to be colocalized with GABA in these subnuclei as well 
(McDonal and Pearson, 1989). Neuropeptides observed at a lower abundance in 
the BLA include vasoactive intestinal peptide (VIP; McDonald and Pearson, 
1989), substance P (Cassell and Gray, 1989), galanin (Kohler et al, 1989), and 
neurotensin (Quirion, 1987), and other neuropeptides observed in the BLA 
include calbindin (CB), calretinin (CR), and parvalbumin (PV; see Shekhar et al, 
2005 for review).  
Electrophysiological recordings were previously conducted in order to 
characterize the interactions between excitatory amino acid (EAA) induced 
EPSPs (i.e. postsynaptic potential changes that depolarize the cell increasing the 
likelihood of initiating a post-synaptic action potential) and GABA-mediated 
IPSPs (i.e., postsynaptic changes that decrease the likelihood of a postsynaptic 
action potential) in the BLA (Rainnie et al, 1991a,b). Even without stimulation, 
single vesicles can occasionally be released into the synapse generating 
miniature EPSPs (mEPSPs) and IPSPs (mIPSPs), and can be characterized by 
amplitude (i.e., quantal size) and frequency (i.e, number of vesicles) defining the 
synaptic response to the release of neurotransmitter in response to a nerve 
impulse (see Purves et al, 2004 for review).   
The electrical stimulation of afferent neurons to the BLA leads to EPSPs 
that are mediated by glutamate, and these EPSPs can be blocked by the 
administration of NMDA antagonists (i.e., AP5) and AMPA and Kainate receptor 
antagonists (CNQX; Rainnie et al, 1991a). In addition, the stimulation of afferents 
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to the BLA also elicits IPSPs that are mediated by GABA, and these IPSPs can 
be blocked by the administration of GABAA antagonists (i.e., BMI) and GABAB 
antagonists (i.e., 2-hydroxy-saclofen; Rainnie et al, 1991b). Therefore, the BLA is 
regulated by multiple feedback loops containing many neurotransmitters and 
neuropeptides that mediate the balance of excitatation and inhibition associated 
with inputs defined by largely sensory inputs and coping inputs from cortical 
regions (see Shekhar et al, 2005 for review).  
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B. Rationale and Objectives 
Developmental disorders are seen at a higher frequency in NF1 patients, 
and can impact cognition, learning, attention and social function. To date, the 
treatment options for NF1-related learning disabilities and social dysfunction are 
lacking at best. The identification of behavioral markers in rodents that are 
relevant to sequelae of a human disease like NF1 represents an important first 
step in advancing this medical research. Understanding the biological 
mechanism(s) that contribute to these gene x phenotype associations can 
provide important targets for developing pharmaceutical treatments as well as 
other forms of clinical intervention.  
The overall hypothesis of this thesis proposal is that mutation at the 
NF1 locus leads to disruptions in social and emotional learning with unique 
disruptions in Pak1-dependent cellular processes in key CNS structures 
that are crucial for the development of normal rodent behaviors. The 
objectives for this thesis were to first screen for behavioral deficits in Nf1+/- mice 
that are associated with social dysfunction, anxiety-like behavior and depression-
associated response and (2) then to characterize the biochemical and cellular 
mechanism(s) that may underlie these deficits. The following five hypotheses 
were generated in light of these main objectives: 
Hypothesis 1:  Nf1+/- mice, as compared to WT, will show deficits in either 
general sociability and social learning, anxiety, and / or behavioral despair and 
learned helplessness, but not olfaction or locomotion. 
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Rationale:  Previous studies indicate that NF1 patients display problems 
with social function (Johnson et al, 1999; Barton and North, 2004; Noll et al, 
2007), and studies have found that NF1 patients display a higher frequency of 
anxiety and mood disorders, including dysthymia and depression (Samuelsson 
and Riccardi, 1989; Zoller and Rembeck, 1999). Objective(s): The first series of 
experiments were designed in order to screen Nf1+/- and WT mice for differences 
in sociability, anxiety, locomotion and olfactory sensory habituation. Due to the 
high rate of emotional learning disabilities associated with NF1, emotional 
learning and memory components were also incorporated to assess short-term 
and long-term social learning and behavioral despair / learned helplessness. 
Olfaction and locomotion were also measured as experimental controls. In 
rodents, olfaction is the primary sensory input for social interactions; therefore, 
olfaction habituation was measured, and locomotor activity was also montitored 
in order to identify differences in movement that could potentially affect measures 
of social behavior and anxiety.   
Hypothesis 2:  The co-deletion of Pak1 in Nf1+/- mice (Nf1+/- / Pak1-/-) will 
restore the deficits in long-term social learning seen in Nf1+/- mice, but will not 
affect preference for social interaction, short-term social learning, anxiety, 
behavioral despair / learned helplessness, olfactory sensory habituation or 
locomotor activity.  
Rationale: PAK1 is a down-stream effector of PI3K that has been shown 
to activate MAPK signaling and mediates crosstalk between PI3K and MAPK 
pathways (Ingram et al, 2001). The in vitro and in vivo inactivation of Pak1 
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normalizes Nf1-related abnormalities seen in cellular proliferation that are MAPK-
dependent and differences in migration seen in mast cells (McDaniel et al, 2008; 
see Figure 2). While no differences were detected in anxiety or behavioral 
despair / learned helplessness between Nf1+/- mice and WT, these phenotypes 
were also characterized to control for potential Pak1-dependent effects on these 
behavioral measures. Objective(s): This series of experiments was designed to 
determine whether the genetic intercross (Nf1+/- / Pak1-/-) would restore the 
deficits in long-term social learning seen in Nf1+/- mice. Behavior tests were 
performed on Nf1+/-, Nf1+/- / Pak1-/-, and Pak1-/- genotypes to assess their 
preference for social interaction, short-term social learning, anxiety, behavioral 
despair / learned helplessness, olfactory sensory habituation and locomotor 
activity. 
Hypothesis 3:  Nf1+/- mice, as compared to WT, will show increases in 
MAPK activation (ERK / p-ERK) in neuronal cells cultured from the frontal cortex. 
The co-deletion of Pak1 in Nf1+/- mice (Nf1+/- / Pak1-/-) will normalize the 
hyperactivation in MAPK associated with the Nf1+/- genotype.  
Rationale: Previous studies have implicated MAPK hyperactivation in 
learning abnormalities seen in Nf1+/- mice (Cui et al, 2008; see Le and Parada, 
2007 for review). Utilizing a genetic intercross to disrupt both Nf1 and Pak1 in all 
cells, it was shown that co-deletion of Pak1, which positively regulates MAPK 
activation, normalizes MAPK hyperactivation in Nf1+/- mast cells (McDaniel et al, 
2008). Objective: To establish that Pak1 co-deletion restores MAPK 
hyperactivation associated with Nf1+/- genotype in neurons in the CNS as it does 
 37 
 
in mast cells, neuronal cells were cultured from the frontal cortex for each 
respective genotype (WT, Nf1+/-, Nf1+/- / Pak1-/-, Pak1-/-), and Western blotting was 
used to quantify the relative activation of ERK (ERK vs. p-ERK) at basal levels 
and following SCF stimulation. 
Hypothesis 4:  Nf1+/- mice, as compared to WT, will show increases in 
inhibitory synaptic currents (IPSCs) in the BLA, and the co-deletion of Pak1 in 
Nf1+/- mice will restore these differences. 
Rationale: Using electrophysiological measures of inhibitory synaptic 
currents, previous studies demonstrate increases in miniature IPSCs (mIPSCs) 
frequency under periods of high-frequency stimulation (12.5 mM KCl) in the 
hippocampus from Nf1+/- mice (Cui et al, 2008). Because the BLA is critical for 
emotional processing of social behavior, abnormalities in IPSCs in the BLA could 
affect processes involved in social learning by reducing neurotransmission from 
glutamatergic projection neurons to various brain regions, including the PFC. 
Objective: In this experiment the whole-cell patch-clamp was used to measure 
isolated spontaneous and miniature inhibitory synaptic currents (IPSC) recorded 
from glutamatergic projection neurons in the BLA of WT, Nf1+/-, Nf1+/- / Pak1-/-, 
Pak1-/- mice.  
Hypothesis 5: Nf1+/- mice, as compared to WT, will show dysregulation in 
proteins in the frontal cortex and BLA that are associated with cellular 
mechanisms involved in social learning, and increases in IPSCs observed in the 
BLA. The co-deletion of Pak in Nf1+/- mice will restore these differences in protein 
expression.    
 38 
 
Rationale: The BLA interacts with the frontal cortex to mediate emotional 
processing and the saliency to sensory cues that are thought to underlie various 
aspects of social behavior, including social learning (see Neural basis of social 
behavior section for review). Objective: To identify potential down-stream targets 
that contribute to the deficits seen in long-term social learning in Nf1+/- mice, 
mass spectrometry was utilized to screen for differences in protein expression 
associated with the heterozygous Nf1 gene deletion (Nf1+/-) in the frontal cortex 
and the BLA. 
 
ADDENDUM 
 
To measure inhibitory synaptic currents (IPSCs) in glutamatergic 
projection neurons dissected from WT, Nf1+/-, Nf1+/- / Pak1-/- and Pak1-/- mice, I 
worked with Dr. Andrei Molosh who is an expert in the field of electrophysiology. 
While we worked closely together during this experiment, Dr. Molosh was the 
primary investigator for these electrophysiological studies. The results from these 
proposed studies are included as an addendum to this dissertation in order to 
better represent and define the scope of this body of work. 
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MATERIALS AND METHODS 
The experimental protocols in this section were designed to address the 
five main hypotheses that are outlined in the Rationale and Objectives section. 
The following section provides a detailed summary of the animals, behavioral 
tests, electrophysiological procedures and protein studies (i.e., Western blotting, 
mass spectrometry) that were utilized in each respective experiment. 
 
A. Animals 
All of the mouse strains tested in these experiments were bred on a 
C57BL/6J background and included the following: (1) Wild-type (WT), (2) Nf1+/-, 
(3) Nf1+/- / Pak1-/- and (4) Pak1-/- mice. The Nf1+/- mice were obtained from Tyler 
Jacks at the Massachusetts Institute of Technology (Cambridge, MA). The Nf1 
allele was genotyped as described previously (Zhang et al, 1998). The Pak1-/- 
strain was obtained from Dr. Jonathan Chernoff (Philadelphia, Pennsylvania). To 
generate the Nf1+/- / Pak1-/- mice, Pak1-/- mice were intercrossed with the Nf1+/- 
strain as previously described (McDaniel et al, 2008). All mice used in these 
experiments were bred in the Indiana University Laboratory Animal Research 
Center.  
 
B. Behavioral Testing 
For all behavioral experiments, adult mice were tested at approximately 
ten weeks of age. To minimize confounds for the behavior studies, the mice were 
male, age-matched and experimentally naïve. Upon arrival at the animal facility, 
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the mice were individually housed in a temperature controlled room (72˚F), and 
were given food and water ad libitum. The housing room was maintained on a 12 
hour light-dark cycle (7:00 am / 7:00 pm). Before testing began, the mice were 
acclimated to the animal facility for six days, and behavioral testing was 
conducted between 8:00 am and 5:00 pm. A battery of behavioral assessments 
were performed including tests of general sociability, social learning / memory, 
anxiety, locomotion, behavioral despair and olfactory sensory habituation (Figure 
5). All procedures were reviewed and approved by the Indiana University School 
of Medicine Institutional Animal Care and Use Committee.  
 
1. Tests of social behaviors and social learning / memory: 
Utilizing a three-chambered apparatus (Sankoorikal et al, 2006), the 
following tests were conducted: (1) preference for social interaction, (2) short-
term social learning / memory, and (3) long-term social learning / memory (see 
Figure 6). The three-chambered apparatus consisted of a rectangular box (20 
inches length x 10 inches width x 9 inches height) that was constructed entirely 
of black Plexiglas. For our experiments, the Plexiglas was lightly sanded to 
minimize reflection. The apparatus was open both on top and bottom, and had 
three interconnecting chambers. The chambers at opposite ends of the 
apparatus were equal in size (7.5 inches x 10 inches), while the middle chamber 
was slightly smaller (4.75 inches x 10 inches).  
Two identical cylinders (3 inches diameter, 5 inches height) constructed of 
black wire were used to house “stimulus” mice (i.e., novel vs. familiar).  For these  
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Figure 5. Timeline for behavioral testing. A battery of behavioral assessments 
was performed to measure sociability, social learning, anxiety, locomotion, 
behavioral despair and olfactory sensory habituation. The mice were acclimated 
to the animal facility for six days before testing began, and were followed by the 
social behavior tests. Four ten minute sessions were conducted that included 
acclimation, preference for social interaction, short-term learning, and long-term 
learning (performed 24 hours later). The elevated plus maze was then utilized to 
measure anxiety-like behavior and then one-trial learning in the EPM (performed 
24 hours later), and the open field test was employed to measure both anxiety-
like behavior and locomotor activity. Next, the forced swim test was used to 
measure behavioral despair and learned helplessness over two days of testing. 
Finally, the olfactory habituation test was utilized to control for differences in 
olfaction and olfactory learning. Each behavioral component was separated by 
48 hours. 
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Figure 6 
(a) Acclimation period (b) Preference for social interaction
(c) Short-term social learning (d) Long-term social learning
Novel Mouse
Now-familiar 
Mouse Familiar MouseNovel Mouse
Novel MouseEmpty cage Empty cage Empty cage
“Test” mouse“Test” mouse
“Test” mouse“Test” mouse
(e) Dimensions of the social behavior apparatus
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Figure 6. Tests of social behaviors and social learning / memory. To 
measure social behavior and social learning / memory, a three-chambered 
rectangular apparatus was utilized consisting of black Plexiglas (Sankoorikal et 
al, 2006). Two wire cages were placed at opposite ends of the apparatus to 
house “stimulus” mice. The behavioral testing apparatus is viewed from above. 
Four ten minute sessions were sequentially conducted to measure preference for 
social interaction and short-term and long-term social learning. (a) During the 
acclimation period, the “test” mouse was presented with two empty cages. (b) 
During the preference for social interaction session, the “test” mouse was 
presented with an empty cage and a cage that housed a novel mouse. (c) During 
the short-term social learning session, the “test” mouse was presented with a 
cage containing the same mouse from the previous session (i.e., now-familiar 
mouse) and a cage containing a novel mouse. (d) During the long-term social 
learning session, the “test” mouse was presented with a cage containing the 
“familiar” mouse from 24 hour earlier and a cage containing a novel mouse. The 
amount of time the “test” mice spent sniffing (i.e., nose pointed toward cage and 
within one inch of cage) each respective cage was determined for each session. 
(e) Dimensions of the behavioral testing apparatus. 
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experiments, the wire cylinders were placed in the center of each chamber at 
opposite ends of the apparatus. The diameter and height of the wire cylinders 
were sufficient for the “stimulus” mouse to move comfortably, and the openings in 
the wire cylinders were evenly spaced allowing for auditory, visual, and olfactory 
investigation as well as some tactile contact. The flooring of the apparatus 
consisted of a blue diaper mat. This diaper mat was replaced with a clean mat, 
and the entire apparatus was cleaned with 90% ethanol following the series of 
tests on each mouse.   
Four 10 minute sessions were conducted that included (1) acclimation 
(two empty cages), (2) preference for social interaction (novel mouse, empty 
cage), (3) short-term learning of social cues (familiar mouse, novel mouse), and 
(4) long-term learning of social cues (familiar mouse - 24 hr later, novel mouse). 
Other than the test of long-term social learning (performed on the following day), 
each of the test sessions were conducted in sequential order and directly 
followed the previous test session. 
a. Acclimation period: At the start of the “acclimation” period, the “test” 
mouse was placed in the center chamber of the apparatus with a new 
diaper mat and both wire cylinders. The “test” mouse was allowed to freely 
explore the entire apparatus for ten minutes. Following the acclimation 
period, the “test” mouse was removed from the apparatus and placed in its 
home cage.   
b. Preference for social interaction (Sankoorikal et al, 2006; Nadler et 
al, 2004; Crawely et al, 2007): At the beginning of the “preference for 
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social interaction” session, a novel mouse was placed in one wire cylinder, 
while the other wire cylinder was left empty. The “test” mouse was then 
reintroduced into the center chamber of the apparatus and allowed to 
freely explore the entire apparatus for ten minutes.  Following the 
preference for social interaction test, the “test” mouse was removed from 
the apparatus and placed in its home cage.   
c. Short-term social learning / memory (refer to Nadler et al, 2004; 
Crawely et al, 2007): A second novel mouse was then placed in the 
second cylinder located on the opposite side of the apparatus from the 
cylinder containing the now-familiar mouse. The “test” mouse was then 
reintroduced into the center chamber of the apparatus and allowed to 
freely explore the entire apparatus for ten minutes.  Following the short-
term social learning / memory test, the “test” mouse was removed from the 
apparatus and placed in its home cage. The second novel mouse then 
was removed from the apparatus and placed in its home cage.   
d. Acclimation to now-familiar mouse: The “test” mouse was then 
reintroduced into the center chamber of the apparatus containing the first 
“now-familiar” mouse and allowed to freely explore the entire apparatus for 
an additional forty-five minutes. After the forty-five minute session, both 
mice were removed from the apparatus and placed in their home cages.   
e. Long-term social learning / memory (refer to Nadler et al, 2004; 
Crawely et al, 2007): On the second day (24 hours later), the “familiar” 
mouse from the previous day was randomly placed under one of the wire 
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cylinders, and another novel mouse was placed under the second wire 
cylinder. The “test” mouse was then reintroduced into the center chamber 
of the apparatus and allowed to freely explore the entire apparatus for a 
ten minute period. Following the long-term social learning / memory test, 
the “test” mouse was removed from the apparatus and placed in its home 
cage.   
All testing sessions were recorded by a video camera that was fixed 
above the social interaction box and independently scored at a later time by two 
individuals who were unaware of the animals‟ genotype. Because the majority of 
social interaction occurs during the first five minutes of a testing session (Nadler 
et al, 2004), the time the “test” mouse spent sniffing the wire cage was measured 
during this time frame.  For the acclimation period, three dependent variables 
were measured to control for potential effects of the testing environment, and 
included (1) the time the “test” mouse spent sniffing (i.e., nose pointed toward 
cage and within one inch of cage) each respective wire cylinder, (2) the time 
spent in each of the side chambers on opposite ends of the apparatus, and (3) 
the number of entries the “test” mouse made into the chambers on opposite ends 
of the apparatus. For all other sessions, the time the “test” mouse spent sniffing 
each respective wire cylinder was scored. 
 
2. Tests of anxiety-like behavior 
The elevated plus maze (EPM) was employed to measure anxiety-like 
behavior (refer to Hogg, 1996) and one-trial learning as defined by the classic 
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reduction in open arm exploration on day 2 (refer to Roy et al, 2009) in mice. The 
EPM apparatus consists of two open and two closed arms, and each arm of the 
EPM measures 2 inches wide and 14 inches long. These arms emanate from a 
central platform that is square (2 x 2 inches) to form a plus shape. The arms and 
central platform of the apparatus are elevated to a height of 24.5 inches above 
the floor. The closed arms are surrounded by a 6 inch high enclosure constructed 
of black Plexiglas. Following each experiment, the entire apparatus was cleaned 
with 90% ethanol.   
Anxiety-like behavior in mice was measured using a five minute trial. At 
the start of each EPM session, the “test” mouse was placed on the center 
platform of the EPM apparatus with its head facing the open arm. The “test” 
mouse was allowed to freely explore the entire apparatus for a period of five 
minutes. The “test” mouse was then removed from the EPM apparatus and 
placed in its home cage. For the one-trial learning test, the “test” mouse is re-
tested in the EPM apparatus for an additional five minute session separated by 
twenty-four hours. For each testing session, two dependent variables were 
measured including (1) the time spent in the open arms and (2) the number of 
entries into the open arms. An open arm entry was defined as having all four 
paws into the arm of the EPM. All testing sessions were recorded by a video 
camera that was fixed above the EPM apparatus and scored at a later time. 
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3. Measurement of locomotor activity 
The “test” mouse was placed in an open field to measure locomotor 
activity and to screen for anxiety-like behavior (Grentsch et al, 1987). The open 
field was a rectangular opaque Plexiglas enclosure (beige in color) that 
measured 19.75 x 19.75 inches wide, and the height of the walls was 15.25 
inches. The flooring was constructed of the same beige Plexiglass, and the top of 
the open field apparatus was open to the environment. To measure locomotor 
activity and anxiety, the “test” mouse was placed in a corner of the open field 
arena, and its movements were recorded under florescent light during a ten 
minute session. A SMART II Video Tracker system (San Diego Instruments, San 
Diego, CA) was used to track movements of the “test” mice. Each enclosure was 
divided into nine pre-defined areas including the center area, four corner areas, 
and four wall areas. The dependent variables to measure anxiety included (1) the 
total time spent in the center region, (2) the total number of entries into the center 
region, and (3) the total distance traveled in the center region. The dependent 
variables to measure exploratory activity included (1) the total distance traveled 
and (2) the total entries within and between each of the nine regions of the 
enclosures. Following each experiment, the entire apparatus was cleaned with 
90% ethanol.   
 
4. Tests of behavioral despair and learned helplessness 
The forced swim test is utilized to measure aspects of behavioral despair 
and learned helplessness in rodents (Porsolt et al, 1977). The forced swim 
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apparatus consisted of a cylindrical chamber constructed of clear Plexiglas with a 
diameter of 8.5 inches and height of 10 inches. The top of the cylinder was left 
open to the environment throughout the experiment. For each trial, the chamber 
was filled with 25 ± 1˚C water to a depth of 5.75 inches.  The “test” mouse was 
then gently placed into the cylinder for 15 minutes. Twenty-four hours later, the 
mice were re-exposed to the same conditions for an additional six minute trial. 
The dependent variable scored for the forced swim test was „immobility‟ or the 
cessation of limb movements except minor involuntary hind limb movements 
during the 2 - 6 minute interval. Following each trial, the water was discarded and 
replaced with clean water adjusted to the aforementioned height and 
temperature. All testing sessions were recorded by a video camera and scored at 
a later time. 
 
5. Measurement of olfactory sensory habituation 
In rodents, dyadic social interactions are largely mediated by olfactory 
response. The olfactory sensory habituation test provides an important indicator 
for differences in the response to olfactory cues (Crawley et al, 2007). For this 
experiment, the “test” mouse was placed in a clean mouse cage constructed of 
clear Plexiglas and containing fresh litter.  Before testing began, the “test” mouse 
was acclimated to its new cage for at least thirty minutes. The “test” mouse was 
then presented with nine cotton applicators that were dipped in either water or 
almond extract (1:100 dilution), or wiped in a zig-zag pattern across the bottom 
surface of a cage that contained an “unfamiliar" mouse. The “unfamiliar” mouse 
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was a singly housed male mouse (C57BL/6J) that had lived in the cage for at 
least 3 days. For each trial the cotton applicators were suspended from the cage 
lid and were presented in the following sequence: (1) water, (2) water, (3) water, 
(4) almond, (5) almond, (6) almond, (7) unfamiliar cage, (8) unfamiliar cage, (9) 
unfamiliar cage. Each swab was presented for 2 minutes for a total session 
lasting 18 minutes per mouse. The amount of time that the “test” mouse spent 
sniffing each cotton swab was scored. All testing sessions were recorded by a 
video camera and scored at a later time. 
 
C. Isolation and culture of neuronal cells from murine strains 
Mouse neurons were aseptically dissected from the frontal cortex and 
cultured from each respective genotype (WT, Nf1+/-, Nf1+/- / Pak1-/-, Pak1-/-). 
Following microdissection by Dr. Rajesh Khanna, neuronal cells were isolated by 
dissociation both enzymatically and mechanically (via trituration through a flame-
polished Pasteur pipette) in a Papain solution (12 units/ml; Worthington) as 
described previously (Brittain et al, 2009). The Papain solution contained 
Leibovitz's L-15 medium (Invitrogen), 0.42 mg/ml cysteine (Sigma), 250 units/ml 
DNase I (type IV; Sigma), 25 mm NaHCO3, penicillin (50 units/ml)/streptomycin 
(50 μg/ml), 1 mm sodium pyruvate, and 1 mg/ml glucose (Invitrogen). After 
dissociation, the cells were gently washed by centrifugation in Neurobasal 
medium containing 20 mg/ml bovine serum albumin and penicillin/streptomycin, 
glucose, pyruvate, and DNase I (as above) and then plated on poly-d-lysine-
coated acid-washed glass coverslips at high density (∼4000 cells/mm2). Growth 
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media (1 ml/well) consisted of Neurobasal medium containing 2% NuSerum, 2% 
B27, supplemented with penicillin/streptomycin (100 units/ml; 50 μg/ml), 0.1 mm 
l-glutamine, and 0.4 mm l-Glutamax (Invitrogen). Cytosine β-d-arabinofuranoside 
(5 μm; Sigma) was added 24 hours after plating to reduce the number of non-
neuronal cells. After four days in culture and two times each week thereafter, half 
of the growth medium was replaced with medium without cytosine β-d-
arabinofuranoside.  
For this experiment, the neuronal cultures were assigned to one of two 
experimental conditions: (i) at basal levels and (ii) following the application of 
recombinant murine stem cell factor (rmSCF; PreproTech) at 10 ng/ml. rmSCF 
was applied to the neuronal cultures for 2 minutes. The cells were then washed 
with ice-cold PBS and lysed in buffer containing Laemmle dye with 10% β-
mercaptoethanol, boiled for five minutes at 95˚C, and then frozen at -80˚C until 
further analysis. 
 
D.  Immunoblotting ERK / p-ERK in mouse cortical neurons 
Whole cell protein extracts were obtained from cultured prefrontal cortical 
neurons in lysis buffer (50mM Tris pH 7.4, 150mM NaCl, 2mM EDTA pH 8.0, 1% 
Triton X-100, 1mM PMSF, 1mM NaF, 1mM Na3VO4,10% glycerol and complete 
protease inhibitor). The samples were sonicated and cellular debris was removed 
by centrifugation at 13,000g for 30 min at 4˚C. Protein concentrations were 
determined using a BCA assay (Thermo Scientific). Equivalent amounts of 
protein was electrophoresed on 10% SDS-PAGE gels, transferred to PVDF 
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membranes (GE Healthcare, Little Chalfont, United Kingdom), and detected by 
Western blotting using the ECL Plus system (Amersham Biosciences). 
Antibodies used were Phospho-ERK Antibody (Cell Signaling Technology), 
ERK1 Antibody (Cell Signaling Technology), and GAPDH (MIllipore). Protein 
isolation and Western blotting was conducted in collaboration with Dr. Rajesh 
Kanna. 
 
E. Electrophysiological measurement of IPSCs in the BLA 
Using the whole-cell patch-clamp, inhibitory synaptic currents were 
measured by Dr. Andrei Molosh from glutamatergic projection neurons in the 
basolateral amygdala (Figure 7). Adult male mice were decapitated using a 
guillotine. The brains were then rapidly removed and placed in oxygenated 
artificial cerebrospinal fluid (ACSF) [130 mM NaCl; 3.5 mM KCl; 1.1 mM KH2PO4; 
1.3 mM MgCl2; 2.5 mM CaCl2; 30 mM NaHCO3; 10 mM glucose]. Coronal slices 
(350 μM) were then prepared containing the BLA. Prior to recording, these slices 
were incubated at room temperature for 1 hour in oxygenated ACSF [95% O2 / 
5% CO2 mixture]. The coronal slices were then transferred to a submersion-type 
slice chamber that was mounted on the stage of a Nikon E600FN Eclipse (Nikon 
Instruments, Melville, NY) microscope and perfused with ACSF [1-2 ml per 
minute] heated to 32˚C. 
Projection neurons were identified according to their characteristic size 
and shape (Pickel et al, 2008). Prior to recording utilizing the whole-cell patch 
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Figure 7. The basolateral amygdala (BLA) in the mouse brain. The figure 
above illustrates a representative coronal slice from the mouse brain that 
contains the BLA (adapted from Paxinos and Watson). Coronal slices (350 μM) 
were prepared containing the BLA for electrophysiological and protein expression 
studies. BLA - basolateral amygdala; CA1 and CA3 - Cornu ammonis areas in 
hippocampus; CeL - central amygdala, lateral division; CeM - central amygdala; 
CMT - central medial thalamic nucleus; DG - Dentate Gyrus; MeA - medial 
amygdala  
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clamp, borosilicate glass electrodes (WPI, Sarasota, FL) (resistance 3-6 MΩ) 
were prepared that contained a potassium gluconate based solution [130 mM K-
Gluconate, 3 mM KCl, 3 mM MgCl2, 5 mM phosphocreatine, 2 mM K-ATP, 0.2 
mM NaGTP, 10 mM HEPES]. While maintaining a holding potential of -60 mV, 
whole-cell access resistances were monitored throughout each experiment. 
These resistances ranged from 5-20 MΩ, and a change of 15% was deemed 
acceptable.  
At the start of each experiment, a series of standardized current clamp 
protocols were performed to confirm that the BLA neuron that was patched was, 
in fact, a BLA projection neuron. Pharmacological agents were administered to 
BLA projection neurons by adding the specified concentration directly to the 
ACSF prior to perfusion. First, spontaneous inhibitory synaptic currents (sIPSC) 
were recorded in the presence of 6,7-Dinitroquinoxaline-2,3-dione (DNQX; 20 
µM) and 3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid (CPP; 10 µM) at a 
holding potential of -55 mV. DNQX and CPP function as AMPA and NMDA 
antagonists. Miniature IPSC (mIPSC) were then recorded following the 
administration of 1 µM tetrodotoxin (TTX), a potent neurotoxin that selectively 
blocks sodium channels. Both sIPSC and miniature IPSC (mIPSC) were 
captured continuously for 30 seconds at a sampling frequency of 20 kHz. 
Spontaneous currents were later analyzed using the pClamp 10.2 (Molecular 
Devices, Sunnyvale, CA). To determine whether the increases in IPSCs detected 
in the BLA were GABA- or glycine-mediated, 1 μM CGP 52432 (GABAB 
antagonist) and 5 μM SR 95531 hydrobromide (GABAA antagonist) were added 
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at the specified concentration directly to the ACSF following the administration of 
DNQX / CPP and then TTX.  
 
F. Quantification of protein in the BLA and PFC 
Tissue slices were prepared following decapitation and transferred to 
centrifuge tubes placed in dry ice for rapid freezing and stored at 80˚C. The 
resulting tissues were first homogenized in a solution containing 400 μl of 50 mM 
ammonium bicarbonate for five minutes. Whole cell protein extracts were 
obtained from brain slices in lysis buffer (30mM Tris, pH7.4, 150mM NaCl, 1% 
Triton X-100, 0.1% SDS, 1mM PMSF, 10mM EDTA, 1mM Na2CO3, 160mM 
NaF, complete protease inhibitor) with ProteoSpin total protein detergent clean 
up micro kit (Norgen, Canada). Then protein concentrations of the lysates were 
determined using a BCA Protein Assay Kit (Pierce, Rockford, IL).  
Protein samples were then subjected to tryptic digestion. After thermal 
denaturation at 95˚C for five minutes, protein samples were reduced through the 
addition of dithiothreitol (DTT) to a final concentration of 5mM and incubated at 
60˚C for 45 minutes. Alkylation was achieved by adding iodoacetamide (IAA) to a 
final concentration of 20 mM prior to incubation at room temperature for 45 
minutes in the dark. A second aliquot of DTT was then added, increasing the final 
concentration of DTT to 10 mM. The samples were then incubated at room 
temperature for 30 minutes to quench the alkylation reaction. Next, trypsin was 
added (1:30 w/w) and microwave-assisted enzymatic digestion was carried out at 
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45˚C for 15 minutes at the power of 50 W, and enzymatic digestion was 
quenched through the addition of neat formic acid.  
LC-MS/MS analyses of the tryptic digests were performed by Dr. Zaneer 
Segu using a Dionex 3000 Ultimate nano-LC system (Dionex, Sunnyvale, CA) 
interfaced to LTQ Orbitrap hybrid mass spectrometer (Thermo Scientific, San 
Jose, CA).  Prior to separation, a 2-µl aliquot of trypsin digestion (1.5 µg protein 
equivalent) was loaded on PepMap300 C18 cartridge (5 µm, 300 Å, Dionex) and 
eluted through the analytical column (150 mm x 100 µm i.d, 200 Å pores) packed 
with C18 magic (Michrom Bioresources, Auburn, CA).  Peptides originating from 
protein tryptic digests were separated using a reversed-phase gradient from 3-
55% B, 97% acetonitrile with 0.1% formic at 500 nl/min flow rate and passed 
through an ADVANCE ionization source (Michrom Bioresources, Auburn, CA).  
 The mass spectrometer was operated in an automated data-dependent 
mode that was switching between MS scan and CID-MS. In this mode, eluted LC 
products undergo an initial full-spectrum MS scan from m/z 300 to 2000 in the 
Orbitrap at 15,000 mass resolutions. Subsequently CID-MS (at 35% normalized 
collision energy) was performed in the ion trap. The precursor ion was isolated 
using the data-dependent acquisition mode with a 2 m/z isolation width to select 
automatically and sequentially five most intense ions (starting with the most 
intense) from the survey scan. The total cycle (6 scans) is continuously repeated 
for the entire LC-MS run under data-dependent conditions with dynamic 
exclusion set to 60 seconds.  Performing MS scanning in the Orbitrap offers high 
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mass accuracy and accurate charge state assignment of the selected precursor 
ions.  
 
G. Bioinformatics and analyses of proteomic data 
Mascot version 2.1.3 was used for all search results obtained in this work. 
The data were searched against Swiss-Prot database for house mouse. Trypsin 
was selected as the enzyme and one missed cleavage was allowed. A 
carbomidomethyl was selected as a fixed modification of all cysteine residues.  
The mass tolerance of both MS and MS/MS data were set to 0.8 Da. Peptides 
with mass accuracy better than 2 ppm and Mascot ion score of 30 and above 
were considered as positive identification. The quantitative analysis of proteins 
was carried out using ProteinQuant Suit developed at Indiana University (Mann 
et al, 2008). Briefly, the raw data obtained from LTQ-Orbitrap XL mass 
spectrometer are converted to MASCOT generic file (MGF). MGF files were then 
parsed with ProtParser subject to specific parsing criteria.  Minimum MOWSE 
score was set to 30 and proteins with two peptides match or above were 
considered as a confident match. Then all parsed files were combined into a 
master file that contains the list of all proteins and peptides identified in the span 
of all the processed LC-MS/MS analyses. Then the combined master files were 
incorporated with their corresponding mzXML files, and were submitted to 
ProteinQuant as described previously (Mann et al, 2008).  
Bioinformatics and statistical analysis of protein data were conducted 
using Partek®Genomics Suite (©Partek Incorporated, St. Louis, MI) in 
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collaboration with Dr. Chirayu Goswami. To analyze the data for each protein, 
the log base 2 was first determined for each data point in order to correct for non-
uniform residuals and to generate absolute values [http://www.sportsci.org]. A 
one-way analyses of variance (ANOVA) analysis was then performed comparing 
protein expression for each respective genotype (i.e., WT, Nf1+/-, Nf1+/- / Pak1-/-, 
and Pak1-/-). When significant differences were obtained, Fisher's protected least 
significant difference (PLSD) post hoc test was applied to conduct individual 
comparisons between groups. Significance was determined at P < 0.05 for all 
analyses.  
 
H. Statistical Analyses 
Data were analyzed using one-way or two-way analyses of variance 
(ANOVAs) or repeated measures ANOVAs. To measure of short-term and long-
term social learning in the social behavior tests, preference for social novelty was 
evaluated using within-genotype repeated measures ANOVAs performed on time 
spent sniffing cages (i.e., nose pointed toward cage and within one inch) using 
cage occupancy (e.g., novel mouse or “familiar” mouse) as the factor. To assess 
anxiety- and depression-like behaviors, two factor (mouse genotype x day) mixed 
ANOVAs were performed on time spent in and entries into the open arm of the 
EPM and percent time spent immobile in the FST, respectively. The data from 
the open field test were analyzed using a student‟s t-test (WT vs. Nf1+/-) or one-
way ANOVAs (Nf1+/- vs. Nf1+/- / Pak1-/- vs. Pak1-/-). For the olfactory habituation 
test, two factor (mouse genotype x scent) mixed ANOVAs were performed on the 
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amount of time spent sniffing the cotton applicator suspended from the cage lid 
for each respective scent. To analyze relative ERK activation (basal levels vs. 
SCF), a two factor (genotype x SCF application) mixed ANOVA was performed 
on ERK1/2 / p-ERK1/2 levels quantified using Western blotting. When significant 
effects were obtained using ANOVAs, the data were further analyzed using post 
hoc Fisher‟s protected least significant difference (PLSD) tests. For 
electrophysiology, statistical analyses included paired t-test and one-way 
ANOVAs using a Dunnet‟s post-hoc. For all comparisons the confidence level for 
significance was set at P < 0.05. 
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RESULTS 
A. Experiment 1: Behavioral effects associated with the 
heterozygous gene deletion of Nf1 (Nf1+/-) in mice 
 
1. Effects on sociability / social learning 
During the acclimation period, the WT and Nf1+/- mice were presented with 
two empty cages that were placed on opposite ends of the three chambered 
apparatus to control for effects of the testing room environment. Statistical 
analyses consisted of a two factor (mouse genotype x cage occupancy) mixed 
ANOVA performed on three dependent variables including time spent sniffing 
each respective cage, time spent in each of the side chambers, and entries into 
each of the side chambers. No differences were observed between genotypes 
[F(1,22)=0.691; P=0.69] or within each genotype [F(1,22)=0.149; P=0.703 for 
empty cage verses empty cage] for the time spent sniffing each respective empty 
cage, and no genotype x cage interaction [F(1,22)=0.125; P=0.13] was detected 
(Figure 8a). Additionally, WT and Nf1+/- strains showed no differences between 
genotypes [F(1,22)=0.073; P=0.79] in time spent in each of the side chambers, 
and exhibited no left-right side preference [F(1,22)=0.327; P=0.573] nor was 
there a genotype x side interaction [F(1,22)=3.831; P=0.063] in the three 
chambered apparatus (Figure 8b).  Additionally, no significant effects of between 
genotypes [F(1,22)=0.077; P=0.79] or within each genotype [F(1,22)=2.390; 
P=0.136] were detected on numbers of entries into the side chambers  
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Figure 8 
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Figure 8. The testing room environment has no effect(s) on time spent 
sniffing cylinders, side preference or entries into the side chambers. During 
the acclimation session, the WT and Nf1+/- mice were presented with two empty 
cages that were placed on opposite ends of the three chambered apparatus. The 
graphs depict (a) the amount of time spent sniffing each cylinder, (b) time spent 
in the chambers on opposite sides of the apparatus, or (c) the total entries into 
each respective chamber. Data were collected for the first five minutes of the ten 
minute session and represent the mean ± SEM for each group. Because the time 
spent in each of the chambers are mutually exclusive rather than independent 
measures, statistical analyses were only performed between the two side 
chambers, and the time spent in the center chamber was presented solely for 
visual comparisons. 
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(Figure 8c). Therefore, these results confirm the absence of an innate side 
preference in the testing room environment. 
 
a. Preference for social interaction 
Following the acclimation period, the WT and Nf1+/- mice were presented 
with a cage containing a novel mouse and an empty cage that were placed on 
opposite ends of the three chambered apparatus in order to assess their 
preference for social interaction. The amount of time the “test” mouse spent 
sniffing a cage containing a novel mouse was measured, as compared to an 
empty cage. Statistical analyses consisted of a two factor (mouse genotype x 
cage occupancy) mixed ANOVA performed on time spent sniffing each 
respective cage. Statistical analysis revealed that both WT and Nf1+/- strains 
spent significantly more time sniffing the cage with a novel mouse over the empty 
cage [F(1,22)=105.8; P=0.0001 for cage with novel mouse verses empty cage]. 
No significant effects were detected between genotypes [F(1,22)=1.544; 
P=0.227] in amount of time spent sniffing the cage, nor was there a genotype x 
cage interaction [F(1,22)=0.881; P=0.358]. Fisher‟s PLSD post hoc analysis 
detected significantly more time sniffing the cage containing the novel mouse 
than the empty wire cage for both WT and Nf1+/- genotypes (P < 0.001; Figure 
9). These findings demonstrate that both genotypes show similar levels of 
sociability. 
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Figure 9. Nf1+/- mice show normal preference for social interaction, as 
compared to WT (n=12/group). During the “preference for social interaction” 
session, the WT and Nf1+/- mice were presented with a cage containing a novel 
mouse and an empty cage that were placed on opposite ends of the three 
chambered apparatus. The graph illustrates the amount of time “test” mouse 
spent sniffing each respective cage. Data were collected for the first five minutes 
of the ten minute session and represent the mean ± SEM for each group. *P < 
0.05 for a within-group comparison between the cage containing the novel 
mouse verses the empty cage. 
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b. Short-term social learning / memory 
Short-term social learning / memory was quantified as a measure of 
“preference for social novelty”, and was defined by the following cage occupancy 
(i.e., novel mouse or “familiar” mouse) as the within-genotype factor. Statistical 
analyses consisted of a two factor (mouse genotype x cage occupancy) mixed 
ANOVA performed on time spent sniffing each respective cage. When presented 
with a cage containing a novel mouse and a cage containing a now-familiar 
mouse (3 min. following exposure to “test” mouse), both WT and Nf1+/- genotypes 
spent significantly more time sniffing the cage containing the novel mouse over 
the cage containing the now-familiar mouse [F(1,22)=15.1; P=0.001 for cage with 
novel mouse verses cage with the familiar mouse]. No differences were observed 
between genotypes [F(1,22)=0.899; P=0.353] in amount of time spent sniffing the 
cages, and genotype x cage interaction [F(1,22)=0.361; P=0.554] was detected. 
Fisher‟s PLSD post hoc analysis detected significantly more time sniffing the 
cage containing the novel mouse over the cage containing the familiar mouse for 
both WT and Nf1+/- genotypes (P < 0.05), and demonstrate that Nf1+/- mice show 
intact short-term social learning (Figure 10a).  
 
c. Long-term social learning / memory 
Similar to the short-term learning / memory test, long-term social learning / 
memory was assessed as a measure of “preference for social novelty”. The WT  
and Nf1+/- mice were presented with a cage containing a novel mouse and cage  
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Figure 10. Nf1+/- mice show intact short-term social learning, but display 
deficits in long-term social learning, as compared to WT (n=12/group). The 
graphs depict the effects of the Nf1 gene deletion on short-term and long-term 
social learning, as measured by their “preference for social novelty”. (a) During 
the “short-term social learning” session, the WT and Nf1+/- mice were presented 
with a cage containing the now-familiar mouse from the previous session and 
one containing a novel mouse that were placed on opposite ends of the three 
chambered apparatus. (b) During the “long-term social learning” session, the WT 
and Nf1+/- mice were presented with a cage containing the same familiar mouse 
from the previous day and a cage containing a novel mouse. The graphs 
illustrate the amount of time “test” mouse spent sniffing each respective cage. 
Data were collected for the first five minutes of the ten minute session and 
represent the mean ± SEM for each group. *P < 0.05 for a within-group 
comparison between the cage containing the now-familiar mouse and the cage 
containing the novel mouse. 
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containing the same familiar mouse from 24 hours earlier. Similar to the short-
term social learning test, statistical analyses consisted of a two factor (mouse 
genotype x cage occupancy) mixed ANOVA performed on time spent sniffing 
each respective cage. No differences were observed between genotypes 
[F(1,22)=2.843; P=0.106] in amount of time spent sniffing the cages and no 
significant genotype x cage interaction was seen [F(1,22)=3.4; P=0.08]. 
However, a significant effect was detected in the amount of time the “test” mice 
spent sniffing each respective cage [F(1,22)=11.7; P=0.002 for cage with novel 
mouse verses cage with the familiar mouse]. Fisher‟s PLSD post hoc analysis 
detected significantly more time sniffing the cage containing the novel mouse 
over the cage containing the familiar mouse for WT (P < 0.005), but no significant 
difference for Nf1+/- genotype (P = 0.25; Figure 10b). Therefore, unlike WT mice, 
these results suggest that Nf1+/- mice are unable to retain and discriminate 
between social cues following a 24 hour delay.  
 
2. Effects on anxiety-like behavior 
Two behavioral tests were employed to test for differences in anxiety-like 
behavior between WT and Nf1+/- mice, including the elevated plus maze (Hogg, 
1996) and the open field test (Grentsch et al, 1987). The elevated plus maze was 
also used to measure one-trial learning to assess whether Nf1+/- show the classic 
reduction in open arm duration and open arm entries seen on day 2 that are 
associated with learning / memory (Roy et al, 2009).  
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a. Elevated plus maze 
For the EPM, statistical analyses consisted of a two factor (mouse 
genotype x time) mixed ANOVA performed on time spent in the open arms and 
entries into the open arms of the EPM. No significant effects were detected 
between genotypes in amount of time spent in the open arm [F(1,22)=0.369; 
P=0.550]  or entries into the open arm [F(1,22)=0.527; P=0.476]  of the EPM, nor 
were there a genotype x time interactions for either open arm time 
[F(1,22)=0.004; P=0.950]  or open arm entries [F(1,22)=0.215; P=0.648]. 
However, statistical analyses revealed a significant effect of time (i.e., 24 hours) 
on both open arm duration [F(1,22)=10.9; P=0.003 for day 2 verses day 1] and 
open arm entries [F(1,22)=11.5; P=0.003 for day 2 verses day 1]. Fisher‟s PLSD 
post hoc analysis detected significant decreases in open arm duration and open 
arm entries on day 2 relative to day 1 for both WT and Nf1+/- genotypes (P < 
0.05; Figure 11a-b). Therefore, these results indicate that WT and Nf1+/- mice 
exhibit no significant differences in anxiety or deficits in one-trial learning, as 
measured by the EPM. 
 
b. Open field test 
The time spent in the center region and entries into the center region of a 
novel open field are inversely correlated with anxiety-like behavior in rodents 
(Grentsch et al, 1987). A student‟s t-test was performed to analyze time spent in 
the center region, entries into the center region, distance traveled in the center 
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Figure 11. Nf1+/- mice exhibit no differences in anxiety-like behavior or one-
trial learning, as compared to WT (n=12/group). Open arm duration and open 
arm entries were measured in WT and Nf1+/- mice during a five minute test using 
the elevated plus maze. Additionally, mice re-tested in the elevated plus maze 24 
hours later to assess one-trial learning. The graphs illustrate (a) the time spent in 
the open arm and (b) entries into the open arm. Data were collected during two 
five minute trials separated by 24 hours and represent the mean ± SEM for each 
group. *P < 0.05 for a within-group comparison between day 1 verses day 2 for 
each respective genotype. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 73 
 
region, total entries, and total distance traveled during a ten minute session in 
Nf1+/- mice, as compared to WT. No differences were detected between in time 
spent in the center region (t=0.193, P=0.849), entries into the center region (t=-
0.760, P=0.455), or distance traveled in the center region (t=-0.909, P=0.373; 
see Figure 12a-c). Additionally, no differences were detected between Nf1+/- and 
WT strains in total entries (t=0.-956, P=0.349) or total distance traveled (t=0.-
1.354, P=0.189) during the ten minute session (see Figure 12d-e). These 
findings suggest that Nf1+/- genotype does not impact anxiety-like behaviors, nor 
does Nf1+/- genotype influence locomotor or exploratory activity in mice. 
 
3. Effects on behavioral despair / learned helplessness 
Previous studies have found an increased risk for development of mood 
disorders in patients diagnosed with NF1 (Samuelsson and Riccardi, 1989; Zoller 
and Rembeck, 1999; Johnson et al, 1999). Swimming “immobility” is thought to 
be positively correlated with depression-like response in rodents (Porsolt et al, 
1977). Percent of time immobile was measured in WT and Nf1+/- during two trials 
that were separated by 24 hours. Statistical analyses for the forced swim test 
consisted of a two factor (mouse genotype x time) mixed ANOVA performed 
percent time spent immobile in the Plexiglas cylinder containing water. No 
significant differences were detected between WT and Nf1+/- genotypes in their 
percent of time immobile [F(1,22)=0.511; P=0.482], nor a genotype x time 
interaction [F(1,22)=0.684; P=0.417]. While a significant effect of day (i.e., 24  
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Figure 12. No differences were detected between Nf1+/- and WT strains 
(n=12/group) in novel open field exploration. A SMART II Video Tracker (VT) 
system was used to track movement of the Nf1+/- and WT mice in a square 
enclosure that was divided into nine pre-defined areas (i.e., center area, four 
corner areas, and four wall areas). The graphs depict (a) time spent in the center 
region, (b) entries into the center region, (c) distance traveled in the center 
region, (d) total entries, and (e) total distance traveled during the ten minute 
session. Data shown represent the mean ± SEM for each group. 
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hours) on their percent of time immobile [F(1,22)=5.087; P=0.034 for day 2 
verses day 1] was detected, post hoc analyses revealed no significant 
differences (Figure 13). Therefore, these results indicate that the Nf1+/- genotype 
does not affect behavioral despair and learned helplessness in mice. 
 
4. Effects on olfactory sensory habituation 
Olfaction is the primary sensory input for social behavior in mice. To 
assess their ability to smell and their habituation to social and non-social odors, 
Nf1+/- and WT mice were presented with cotton applicators dipped in water, 
almond extract and the scent of a novel mouse (Crawley et al, 2007). To obtain 
the scent of a novel mouse, a cotton applicator wiped in a zig-zag pattern across 
the bottom surface of a cage that contained an unfamiliar mouse that lived in the 
cage for at least three days. Two factor (mouse genotype x scent) mixed 
ANOVAs were performed on the amount of time spent sniffing the cotton 
applicator suspended from the cage lid. The scents that were presented included 
(1) water, (2) diluted almond extract, (3) novel mouse. No significant differences 
were detected between Nf1+/- and WT genotypes for the time spent sniffing 
cotton applicators dipped in water [F(1,12)=1.692; P=0.218], almond extract 
[F(1,12)=0.682; P=0.425], or scent of a novel mouse [F(1,12)=0.005; P=0.945], 
nor was a genotype x scent interaction detected for water [F(1,12)=1.294; 
P=0.278], almond extract [F(1,12)=0.1.395; P=0.261], or scent of a novel mouse 
[F(1,12)=0.032; P=0.860]. Figure 14 illustrates that both strains exhibited a  
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Figure 13. Nf1+/- and WT mice (n=12/group) show no differences in their 
percent of time immobile in the forced swim test (FST), a measure of 
behavioral despair and learned helplessness. Swimming “immobility” was 
assessed during the 2-6 minute interval on day 1 and day 2. Data shown 
represent the mean ± SEM of the percent of time immobile for each group. 
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Figure 14. Nf1+/- and WT strains show normal olfaction in response to social 
and non-social odors (n=12/group). To assess non-social and social olfactory 
response, Nf1+/- and WT strains were presented with cotton applicators dipped in 
water, almond extract and the scent of a novel mouse (in triplicate). Data shown 
represent the mean ± SEM for each group. 
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significant habituation to the cotton applicator soaked with either water or almond 
extract, demonstrating moderate sniffing that was followed by a reduction in 
sniffing across the second and third exposures (P < 0.05). The most significant 
response was elicited from the social smell or the cotton applicator wiped across 
a cage containing a novel mouse that had no previous contact with the “test” 
mouse (P < 0.01). Therefore, both Nf1+/- and WT genotypes showed no 
differences in their ability to smell.  
 
B. Experiment 2: Behavioral effects associated with the co-deletion 
of Pak1 in Nf1+/- (Nf1+/-/ Pak1-/-) mice 
 
1. Effects on sociability / social learning 
Experiment 1 demonstrates normal preference for social interaction and 
intact short-term social learning / memory, but deficits in long-term social learning 
/ memory seen in mice with the heterozygous gene deletion of Nf1 (Nf1+/-), as 
compared to WT. In addition, no differences were observed between Nf1+/- mice 
and WT in measures of anxiety-like behavior (EPM, open field test) or 
depression-associated response (forced swim test). The purpose of this 
experiment is to determine whether the genetic inactivation of Pak1 in Nf1+/- 
(Nf1+/-/ Pak1-/-) mice would restore the deficits in long-term social learning / 
memory, as it does for in vitro and in vivo gain-in-function phenotypes (i.e., 
cellular proliferation, cellular migration) observed in Nf1 haploinsufficient mast 
cells (McDaniel et al, 2008).  
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a. Preference for social interaction 
For the preference for social interaction test, statistical analyses consisted 
of a two factor (mouse genotype x cage occupancy) mixed ANOVA performed on 
time spent sniffing each respective cage. When presented with a cage containing 
a novel mouse and an empty cage, statistical analysis revealed that Nf1+/-, Nf1+/-/ 
Pak1-/-, and Pak1-/- mice all spent significantly more time sniffing the cage 
containing the novel mouse over the empty cage [F(1,26)=100.45; P=0.001 for 
cage with novel mouse verses cage with the familiar mouse]. No significant 
effects were detected between genotypes [F(2,26)=0.713; P=0.500] in amount of 
time spent sniffing the cage, nor was there a genotype x cage interaction 
[F(2,26)=1.114; P=0.343]. Fisher‟s PLSD post hoc analysis detected significantly 
more time sniffing the cage containing the novel mouse than the empty wire cage 
for Nf1+/-, Nf1+/-/ Pak1-/-, and Pak1-/- genotypes (P < 0.001; Figure 15). These 
findings demonstrate that Pak1 deletion in mice does not significantly affect 
levels of sociability, as compared to Nf1+/- mice. 
 
b. Short-term social learning / memory 
To analyze short-term social learning / memory, statistical analyses 
consisted of a two factor (mouse genotype x cage occupancy) mixed ANOVA 
performed on time spent sniffing each respective cage. When presented with a 
cage containing a novel mouse and a cage containing a now-familiar mouse, 
Nf1+/-, Nf1+/-/ Pak1-/-, and Pak1-/- genotypes spent significantly more time sniffing  
 
 81 
 
 
 
 
 
Figure 15. The deletion of Pak1 (Pak1-/-) in mice does not affect preference 
for social interaction, as compared to Nf1+/- mice. During the “preference for 
social interaction” session, Nf1+/- (n=12), Nf1+/- / Pak1-/- (n=11), Pak1-/- (n=6) mice 
were presented with a cage containing a novel mouse and an empty cage that 
were placed on opposite ends of the three chambered apparatus. The graph 
illustrates the amount of time “test” mouse spent sniffing each respective cage. 
Data were collected for the first five minutes of the ten minute session and 
represent the mean ± SEM for each group. *P < 0.05 for a within-group 
comparison between the cage containing the novel mouse verses the empty 
cage. 
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the cage containing the novel mouse over the cage containing the now-familiar 
mouse [F(1,26)=32.66; P=0.001 for cage with novel mouse verses cage with the 
familiar mouse]. No differences were observed between genotypes 
[F(2,26)=1.659; P=0.210] in amount of time spent sniffing the cages, and 
genotype x cage interaction [F(2,26)=1.537; P=0.234]  was detected. Fisher‟s 
PLSD post hoc analysis detected significantly more time sniffing the cage 
containing the novel mouse over the cage containing the familiar mouse for Nf1+/-
, Nf1+/-/ Pak1-/-, and Pak1-/- mice (P < 0.05), and demonstrate that all three strains 
demonstrate intact short-term social learning (Figure 16a).  
 
c. Long-term social learning / memory 
Similar to the short-term social learning / memory test, statistically 
analyses for the long-term social learning / memory consisted of a two factor 
(mouse genotype x cage occupancy) mixed ANOVA performed on time spent 
sniffing each respective cage. When Nf1+/-, Nf1+/-/ Pak1-/-, and Pak1-/- mice were 
presented with a cage containing a novel mouse and a cage containing the same 
familiar mouse from 24 hours earlier, no differences were observed between 
genotypes [F(2,26)=0.117; P=0.890] in amount of time spent sniffing the cages 
and no significant genotype x cage interaction was seen [F(2,26)=3.04; P=0.065]. 
However, a significant effect was detected in the amount of time the “test” mice 
spent sniffing each respective cage [F(1,26)=7.325; P=0.012 for cage with novel 
mouse verses cage with the familiar mouse]. Similar to the findings from 
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Figure 16. The co-deletion of Pak1 (Pak1-/-) in Nf1+/- mice does not affect 
short-term social learning, but restores the deficits in long-term social 
learning seen in Nf1+/- mice. The graphs depict the effects of the Pak1 gene 
deletion on short-term and long-term social learning, as measured by their 
“preference for social novelty”. (a) During the “short-term social learning” session, 
the Nf1+/- (n=12), Nf1+/- / Pak1-/- (n=11), Pak1-/- (n=6) mice were presented with a 
cage containing the now-familiar mouse from the previous session and one 
containing a novel mouse that were placed on opposite ends of the three 
chambered apparatus. (b) During the “long-term social learning” session, the 
Nf1+/-, Nf1+/- / Pak1-/-, Pak1-/- mice were presented with a cage containing the 
same familiar mouse from the previous day and a cage containing a novel 
mouse. The graphs illustrate the amount of time “test” mouse spent sniffing each 
respective cage. Data were collected for the first five minutes of the ten minute 
session and represent the mean ± SEM for each group. *P < 0.05 for a within-
group comparison between the cage containing the now-familiar mouse and the 
cage containing the novel mouse. 
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experiment 1, Fisher‟s PLSD post hoc analysis detected no significant difference 
in the amount of time Nf1+/- genotype spent sniffing the cage containing the novel 
mouse over the cage containing the familiar mouse, but both Nf1+/-/ Pak1-/- and 
Pak1-/- genotypes spent significantly more time sniffing the cage containing the 
novel mouse over the cage containing the familiar mouse (P < 0.05; Figure 16b). 
Therefore, unlike Nf1+/- mice, Nf1+/- / Pak1-/- mice are able to retain and 
discriminate between social cues following a 24 hour delay indicating that the 
genetic inactivation of Pak1 restores the deficits in long-term social learning seen 
in Nf1+/- mice.  
 
2. Effects on anxiety-like behavior 
In experiment 1, no significant differences were detected in anxiety-like 
behavior or one-trial learning comparing WT and Nf1+/- genotypes, as measured 
by the elevated plus maze. In experiment 2 the EPM was used to assess anxiety-
like behavior and one-trial learning associated with the homozygous Pak1 gene 
deletion in Nf1+/- mice. For the EPM, statistical analyses consisted of a two factor 
(mouse genotype x day) mixed ANOVA performed on time spent in the open 
arms and entries into the open arms of the EPM. No differences were detected 
between genotypes in amount of time spent in the open arm [F(2,22)=1.797; 
P=0.186], and no genotype x cage interaction was seen [F(2,26)=1.293; 
P=0.292]. Similar to experiment 1, statistical analyses revealed a significantly 
effect of time on open arm duration [F(2,26)=36.61; P=0.001 for day 2 verses day 
1]. Fisher‟s PLSD post hoc analysis detected significant decreases in open arm 
duration on day 2 relative to day 1 for Nf1+/-, Nf1+/-/ Pak1-/-, and Pak1-/- genotypes 
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(P < 0.05; Figure 17a). Additionally, no differences were observed between 
genotypes in entries into the open arm [F(2,26)=1.923; P=0.166]  of the elevated 
plus maze, nor was there a genotype x time interaction for open arm entries 
[F(2,26)=0.633; P=0.539]. Statistical analyses did reveal a significant effect of 
time on open arm entries [F(1,26)=47.39; P=0.001 for day 2 verses day 1]. 
Fisher‟s PLSD post hoc analysis detected significant decreases in open arm 
duration and open arm entries on day 2 relative to day 1 for Nf1+/-, Nf1+/-/ Pak1-/-, 
and Pak1-/- genotypes (P < 0.05; Figure 17b). Therefore, the findings indicate 
Nf1+/-, Nf1+/-/ Pak1-/-, and Pak1-/- genotypes show no significant differences in 
anxiety-like behaviors, as measured by the EPM on day 1. In addition, all three 
genotypes showed the classic reduction in open arm time and open arm entries 
observed on day 2 consistent with normal one-trial learning in the EPM. 
 
3. Effects on behavioral despair / learned helplessness 
In experiment 1, no significant differences were detected in depression-
associated immobility comparing WT and Nf1+/- genotypes, as measured by the 
forced swim test. In experiment 2, the forced swim test was again employed to 
assess swimming immobility in Nf1+/-, Nf1+/-/ Pak1-/-, and Pak1-/- genotypes. 
Statistical analyses for the forced swim test consisted of a two factor (mouse 
genotype x time) mixed ANOVA performed percent time spent immobile in the 
Plexiglas cylinder containing water. Significant differences were detected 
between Nf1+/-, Nf1+/-/ Pak1-/-, and Pak1-/- genotypes in their percent of time 
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Figure 17. Nf1+/- / Pak1-/- and Pak1-/- mice exhibit no differences in anxiety-
like behavior or one-trial learning, as compared to Nf1+/- mice. Open arm 
duration and open arm entries were measured in Nf1+/- (n=12), Nf1+/- / Pak1-/- 
(n=11), Pak1-/- (n=6) mice during a five minute test using the elevated plus maze. 
Additionally, mice were re-tested in the elevated plus maze 24 hours later to 
assess one-trial learning. The graphs illustrate (a) the time spent in the open arm 
and (b) entries into the open arm entries. Data were collected during two five 
minute trials separated by 24 hours and represent the mean ± SEM for each 
group. *P < 0.05 for a within-group comparison between day 1 verses day 2 for 
each respective genotype. 
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immobile [F(2,26)=6.905; P=0.004], but no significant  genotype x time 
interaction was observed [F(2,26)=0.496; P=0.615]. Additionally, a significant 
effect of day on their percent of time immobile was detected [F(1,26)=9.237; 
P=0.005 for day 2 verses day 1]. Post hoc analyses revealed significant 
decreases in the percent of time immobile Nf1+/-/ Pak1-/-, and Pak1-/- genotypes, 
as compared to Nf1+/- mice (P < 0.05; Figure 18). Therefore, these results 
indicate that the Pak1 deletion is associated with decreases in depression-
associated immobility in mice. 
 
4. Effects on olfactory sensory habituation 
In experiment 1, no differences were detected in olfaction or olfactory 
habituation between Nf1+/- and WT genotypes, as measured by the olfactory 
sensory habituation test. To measure the ability of the Nf1+/-, Nf1+/- / Pak1-/-, and 
Pak1-/- mice to smell and their habituation to social and non-social odors, Nf1+/- 
and WT mice were presented with cotton applicators dipped in water, almond 
extract and the scent of a novel mouse (Crawley et al, 2007). Two factor (mouse 
genotype x scent) mixed ANOVAs were performed on the amount of time spent 
sniffing the cotton applicator suspended from the cage lid. The scents that were 
presented included (1) water, (2) diluted almond extract, (3) novel mouse. No 
significant differences were detected between Nf1+/-, Nf1+/-/ Pak1-/-, and Pak1-/- 
genotypes for the time spent sniffing cotton applicators dipped in water 
[F(2,15)=1.219; P=0.323], almond extract [F(2,15)=0.145; P=0.867], or scent of a  
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Figure 18. Nf1+/- / Pak1-/- and Pak1-/- mice show significant decreases in their 
percent of time immobile in the forced swim test (FST), as compared to 
Nf1+/- mice. Swimming “immobility” was assessed during the 2-6 minute interval 
on day 1 and day 2. Data shown represent the mean ± SEM of the percent of 
time immobile for each group. †P < 0.05 for a between-group comparison verses 
Nf1+/- genotype. 
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novel mouse [F(2,15)=0.774; P=0.479], nor was a genotype x scent interaction 
detected for water [F(2,15)=0.589; P=0.567], almond extract [F(2,15)=1.481; 
P=0.259], or scent of a novel mouse [F(2,15)=2.354; P=0.129]. Similar to the 
findings from experiment 1, all three strains exhibited a significant habituation to 
the cotton applicator soaked with either water or almond extract, demonstrating 
moderate sniffing that was followed by a reduction in sniffing across the second 
and third exposures (P < 0.05), and the most significant response was elicited 
from the scent of the novel mouse (P < 0.01; Figure 19).  
 
C. Experiment 3: Role of Nf1 and Pak1 genes on ERK activation in 
murine cortical neurons 
McDaniel et al (2008) demonstrates that the co-deletion of Pak1 gene in 
Nf1+/- mast cells normalizes MAPK hyperactivation associated with the Nf1+/- 
gene deletion (McDaniel et al, 2008).  To determine whether the co-deletion of 
Pak1 gene would restore the Nf1+/--related MAPK hyperactivation in CNS 
neurons, mouse cortical neurons were cultured in vitro for 5 days and harvested 
from WT, Nf1+/-, Nf1+/- / Pak1-/- and Pak1-/- mice. The resulting neurons were 
challenged with 10 ng/ml of stem cell factor (SCF) for approximately 2 minutes, 
and ERK1/2 / p-ERK1/2 levels were quantified using Western blotting. To assess 
ERK activation in mouse cortical neurons (basal levels vs. SCF), a two factor 
(genotype x SCF application) ANOVA was performed on ERK1/2 / p-ERK1/2 
  
 
 92 
 
 
 
 
Figure 19. Nf1+/- and WT strains show normal olfaction in response to social 
and non-social odors (n=12/group). To assess non-social and social olfactory 
response, Nf1+/- (n=12), Nf1+/- / Pak1-/- (n=11), Pak1-/- (n=6) mice were presented 
with cotton applicators dipped in water, almond extract and the scent of a novel 
mouse (in triplicate). Data shown represent the mean ± SEM for each group. 
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content characterized using Western blotting, a semi-quantitative measure. 
Significant differences were detected between genotypes WT, Nf1+/-, Nf1+/- / 
Pak1-/- and Pak1-/- in ERK1/2 / p-ERK1/2 levels [F(3,8)=11.01; P=0.003], and 
genotype x SCF interaction was detected [F(3,8)=41.64; P=0.0001]. In addition, 
statistical analyses revealed a highly significant effect of SCF on ERK activation 
[F(1,8)=247.37; P=0.0001 for SCF verses basal]. Fisher's PLSD post hoc tests 
were applied to conduct individual comparisons within and between groups. 
Consistent with the findings from McDaniel et al (2008), no differences were 
detected in ERK1/2 activation between cultures at basal levels (Figure 20). 
Stimulation with SCF for 2 minutes resulted in a significant increase in p-ERK1/2 
relative to ERK1/2 in WT, Nf1+/-, Nf1+/- / Pak1-/- genotypes. As compared to WT, 
Nf1+/- genotype showed significantly greater ERK1/2 activation, and the co-
deletion of Pak1 in Nf1+/- neuronal cultures (i.e., Nf1+/- / Pak1-/-) decreased the 
hyperactivation of p-ERK1/2 to levels consistent with WT (P < 0.05). The 
administration of SCF to Pak1-/- cultured neurons yielded no effect on ERK1/2 
activation. Therefore, these findings indicate that the Nf1+/- genotype leads to 
MAPK hyperactivation following SCF stimulation, and this hyperactivation is 
restored by the co-deletion of Pak1 in cultured cortical neurons in mice. 
Significance was determined at P < 0.05 for all analyses. 
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Figure 20. The co-deletion of Pak1 (Nf1+/- / Pak1-/-) restores MAPK 
hyperactivation associated with Nf1+/- in neuronal cultures. Western blotting 
was used to quantify p-ERK1/2 in cultured cortical neurons at basal levels and 2 
minutes following stimulation with SCF (10 ng/ml). Phospho-ERK1/2 was 
quantified by immunoblotting using phospho-specific antibodies, and total 
ERK1/2 was used as loading controls. Each value represents the mean and the 
error bars represent the standard error of the mean of three independent 
experiments (*P < 0.05 vs basal levels; 
†
P < 0.05 vs. WT). 
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D. Experiment 4: Role of Nf1 and Pak1 in the regulation of inhibitory 
synaptic currents in the BLA in mice 
 
1. Effects of Nf1+/- genotype on IPSCs in the BLA 
Utilizing the whole-cell patch clamp, isolated spontaneous inhibitory 
synaptic currents (sIPSC) and miniature IPSC (mIPSC) were recorded at a 
standardized holding potential of -55 mV in WT (n=11) and Nf1+/- (n=11) mice. To 
assess inhibitory IPSCs in the BLA, statistical analyses using a paired t-test were 
performed to compare WT and Nf1+/- genotypes. In the presence of AMPA and 
NMDA antagonists (DNQX, CPP), Nf1+/- mice showed no differences in sIPSC 
amplitude [t10=0.23, P=0.823] or mIPSC [t10=0.057, P=0.956] in the presence of 
tetrodotoxin (TTX), as compared to WT (Figure 21a). However, Nf1+/- mice 
exhibited significant increases in sIPSC [t10=2.518, P=0.02] and mIPSC 
[t10=2.368, P=0.028] frequency in BLA projection neurons, as compared to WT 
(Figure 21b). In the presence of GABAA antagonist (SR 95531 hydrobromide) 
and GABAB antagonist (CGP 52432), the mIPSCs observed in glutamatergic 
projection neurons in the BLA were entirely blocked, an effect consistent with 
GABA inhibition. 
 
2. Effects of Pak1 co-deletion in Nf1+/- mice on IPSCs in BLA 
As before, the whole-cell patch clamp was used to measure sIPSC and 
mIPSC recorded at -55 mV in Nf1+/- (n=11), Nf1+/- / Pak1-/- (n=11), and Pak1-/-  
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Figure 21. Nf1+/- mice exhibit no differences in sIPSC and mIPSC amplitude, 
but increases in sIPSC and mIPSC frequency in BLA, as compared to WT 
(n=11/group). Isolated spontaneous inhibitory synaptic currents (sIPSC) and 
miniature IPSC (mIPSC) were recorded from BLA glutamatergic projection 
neurons at a standardized holding potential of -55 mV in WT and Nf1+/- mice. The 
graphs illustrate the (a) sIPSC and mIPSC amplitude and (b) sIPSC and mIPSC 
frequency. Data represent the mean ± SEM for each group. *P < 0.05 for 
comparison between genotypes [Calibration: 1s, 40 pA.]. 
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(n=11) mice. Statistical analyses included one-way ANOVAs comparing each 
respective genotype. When significance was obtained, Dunnets‟ post-hoc tests 
were applied to conduct individual comparisons between genotypes on IPSC 
amplitude and frequency. In the presence of AMPA and NMDA antagonists, 
Nf1+/-, Nf1+/- / Pak1-/-, and Pak1-/- mice showed no differences in sIPSC amplitude 
[F(2,36)=0.5, P=0.61 for Nf1+/- / Pak1-/-, and Pak1-/- versus Nf1+/-] or mIPSC 
[F(2,36)=0.527, P=0.595 for Nf1+/- / Pak1-/-, and Pak1-/- versus Nf1+/-] in the 
presence of TTX, as compared to WT (Figure 22a). However, Nf1+/- / Pak1-/-, and 
Pak1-/- mice showed significant decreases in sIPSC [F(2,26)=4.606, P=0.016 for  
Nf1+/- / Pak1-/- and Pak1-/- versus Nf1+/-] and mIPSC [F(2,26)=14.54, P<0.0001 for 
Nf1+/- / Pak1-/-, and Pak1-/- versus Nf1+/-] frequency in BLA projection neurons, as 
compared to Nf1+/- mice (Figure 22b). Therefore, the co-deletion of Pak1 in Nf1+/- 
mice normalizes the increases in spontaneous and minuture IPSCs observed in 
glutamatergic projection neurons in BLA of Nf1+/- mice. 
 
E. Experiment 5: Role of Nf1 and Pak1 genes in the regulation of 
protein expression in the PFC and BLA in mice 
Mass spectrometry was utilized to screen for differences in protein 
expression in the PFC and BLA associated with Nf1+/-, Nf1+/- / Pak1-/- and Pak1-/- 
genotypes, as compared to WT (n=6 per group). Partek Genomics Suite 
(©Partek Incorporated, St. Louis, MO) was used to analyze these data. The log  
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Figure 22. Nf1+/- / Pak1-/- and Pak1-/- mice show no differences in sIPSC and 
mIPSC amplitude, but decreases in sIPSC and mIPSC frequency in BLA, as 
compared to Nf1+/- mice (n=11/group). Isolated spontaneous inhibitory synaptic 
currents (sIPSC) and miniature IPSC (mIPSC) were recorded from BLA 
glutamatergic projection neurons at a standardized holding potential of -55 mV in 
Nf1+/-, Nf1+/- / Pak1-/- and Pak1-/- mice. The graphs depict the (a) sIPSC and 
mIPSC amplitude and (b) sIPSC and mIPSC frequency. Data represent the 
mean ± SEM for each group. *P < 0.05 for comparison to Nf1+/- genotype 
[Calibration: 1s, 40 pA]. 
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base2 was first determined for each data point associated with each protein 
identified using mass spectometry. A one-way ANOVA analysis was then 
performed comparing protein expression for each respective genotype (i.e., WT, 
Nf1+/-, Nf1+/- / Pak1-/-, and Pak1-/-). Significance was determined at P < 0.05 for all 
analyses. When significant differences were obtained using the one-way 
ANOVA, Fisher's PLSD post hoc test was applied to conduct individual 
comparisons between groups. Proteins of interest were selected based on the 
following criteria: (1) significant differences between WT vs. Nf1+/- group, (2) 
significant differences between Nf1+/- vs. Nf1+/- / Pak1-/- group, and (3) were 
directionally consistent with a rescue.  
In the PFC, the following twenty proteins were identified that showed 
significant differences in expression between WT vs. Nf1+/- group and (2) 
significant differences between Nf1+/- vs. Nf1+/- / Pak1-/- group, and were 
consistent with a rescue (see Table 1 and Table 2). These proteins include the 
following: (1) LSAMP [F(3,20)=5.61; P=0.0058], (2) CALB1 [F(3,20)=7.17; 
P=0.0019], (3) ACTS [F(3,20)=5.71; P=0.0054], (4) HNRH1 [F(3,20=3.21; 
P=0.045], (5) CAPRI [F(3,20)=13.00; P=0.0001], (6) H2A2B [F(3,20)=4.11; 
P=0.0199], (7) NUCL [F(3,20)=6.02; P=0.0043], (8) AP1B1 [F(3,20)=4.15; 
P=0.0194], (9) MBP [F(3,20)=4.53; P=0.0140], (10) DREB [F(3,20)=5.69; 
P=0.0055], (11) CLCB [F(3,20)=3.95; P=0.0232], (12) THY1 [F(3,20)=4.21; 
P=0.0185], (13) MAP1A [F(3,20)=11.86; P=0.0001], (14) ENOA [F(3,20)=13.77; 
P=0.0001], (15) STXB1 [F(3,20)=9.40; P=0.0001], (16) DHE [F(3,20)=8.09; 
P=0.0010], (17) LDHA [F(3,20)=8.65; P=0.0007], (18) DYL2 [F(3,20)=3.44; 
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P=0.0365], (19) DYN1 [F(3,20)=4.28; P=0.0173], (20) NACAM [F(3,20)=5.48; 
P=0.0065], and (21) CAZA2 [F(3,20)=4.57; P=0.0135].  
In the BLA, ADAM22 [F(3,20)=12.13; P=0.0001] was identified displaying 
significant differences in expression between WT vs. Nf1+/- group and significant 
differences between Nf1+/- vs. Nf1+/- / Pak1-/- group consistent with a rescue (see 
Table 1 and Table 2). Following protein identification, Pubmed and Protein 
search engines (www.ncbi.nlm.nih.gov) were used to further characterize 
proteins identified in the PFC and BLA based on their known biology and their 
relevance to NF1-related phenotypes. For a review of protein functions, see Role 
of Nf1 and Pak1 in the regulation of protein expression in the BLA and PFC 
section in Discussion. 
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Table 1: Protein expression differences seen in Nf1-deficient mice are  
               restored by the co-deletion of Pak1 gene in the PFC and BLA 
 
 
   Rescued by 
Protein Locus ID Fold-change Pak1 deletion Description 
 
        
Prefrontal cortex: 
 
LSAMP Q8BLK3 8.25 Full rescue Limbic system-associated membrane protein 
CALB1 P12658 6.21 Full rescue Calbindin 
ACTS P68134 5.15 Full rescue Alpha-actin-1 
HNRH1 O35737 4.07 Full rescue Heterogeneous nuclear ribonucleoprotein H 
CAPRI Q60865 3.53 Full rescue Caprin-1 
H2A2B Q64522 3.44 Full rescue Histone H2A type 2-B 
NUCL P09405 3.21 Full rescue Nucleolin 
AP1B1 O35643 2.87 Full rescue AP-1 complex subunit beta-1 
MBP P04370 2.47 Full rescue Myelin basic protein 
DREB Q9QXS6 2.03 Full rescue Drebrin 
CLCB Q6IRU5 1.86 Full rescue Clathrin light chain B 
THY1 P01831 1.57 Full rescue Thy-1 membrane glycoprotein 
MAP1A Q9QYR6 1.49 Full rescue Microtubule-associated protein 1A 
ENOA P17182 -1.37 Full rescue Alpha-enolase 
STXB1 O08599 -1.63 Full rescue Syntaxin-binding protein 1 
DHE P26443 -1.88 Full rescue Glutamate dehydrogenase 1 
LDHA P06151 -2.02 Full rescue L-lactate dehydrogenase A chain 
DYL2 Q9D0M5 -2.27 Full rescue Dynein light chain 2 
DYN1 P39053 -2.56 Full rescue Dynamin-1 
NACAM P70670 -3.12 Full rescue Nascent-associated complex subunit alpha 
CAZA2  P47754  -3.57 Full rescue F-actin-capping protein subunit alpha-2 
 
Basolateral amygdala: 
 
 ADAM22 Q9R1V6 -6.17 Partial rescue ADAM metallopeptidase domain 22 
 
 
*P < 0.05 vs. WT
-
; One-way ANOVA [performed on log transformed protein expression data] 
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DISCUSSION 
Neurofibromatosis type 1 is one of the most common single gene 
disorders in humans. While NF1 is diagnosed by the presentation of physical 
features, a higher incidence of developmental behavioral disorders is seen 
including learning disabilities, attention problems, social deficits and psychiatric 
disorders. Silva et al (1997) was the first to find that Nf1+/- mice display spatial 
learning deficits comparable to those observed in NF1 patients. Subsequent 
studies in the hippocampus have implicated the hyperactivation of RAS-
dependent signaling, increased GABA-mediated inhibition, and deficits in LTP as 
potential mechanisms underlying these spatial learning deficits (Costa et al, 
2002; Li et al, 2005; Cui et al, 2008). However, neurofibromin is not isolated to 
the hippocampus, but is expressed throughout the CNS, including the prefrontal 
cortex and the amygdala. Therefore, a primary objective for the present 
dissertation was to characterize the Nf1+/- mouse model for abnormalities in 
processes associated with social and emotional learning.  
For this purpose, Nf1+/- mice were first screened for deficits in behaviors 
including social interaction and social learning, anxiety-like behavior, one-trial 
learning (EPM), and depression-associated response. This series of experiments 
revealed that Nf1+/- mice show selective deficits in long-term social learning / 
memory. Next, utilizing a genetic intercross, it was further demonstrated that the 
co-deletion of Pak1 restores these deficits in long-term social learning / memory. 
The heterozygous Nf1 gene deletion (Nf1+/-) is associated with hyperactivation of 
the MAPK signaling pathway (see Le and Parada, 2007 for review). Similar to 
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previous findings in mast cells (McDaniel et al, 2008), the immediate effects of 
the co-deletion of Pak1 on stem cell factor (SCF)-mediated MAPK 
hyperactivation were also demonstrated in Nf1+/- neurons cultured from the PFC. 
Consistent with previous findings in CA1 pyramidal cells of hippocampal slices 
(Costa et al, 2002; Cui et al, 2008), electrophysiological methods found 
increased inhibitory synaptic currents (IPSCs) in glutamatergic projection 
neurons in the BLA, a brain region that is critical for learning social cues. These 
increases in IPSC frequency seen in Nf1+/- mice were restored by the co-deletion 
of Pak1 gene. Utilizing the same genetic intercross method, mass spectrometry 
was employed to identify novel protein candidates that may contribute to these 
abnormalities associated with the Nf1+/- genotype. 
 
A. Nf1+/- mutation leads to sustained deficits in social learning 
The Nf1+/- strain provides a unique model to study genetic, molecular, 
and cellular mechanisms that are responsible for the learning disabilities, 
attention deficits, social and emotional problems associated with NF1 (see 
Shilyansky et al, 2010 for review). Previous studies indicate that NF1 children 
display social problems including with social withdrawal, poor interpersonal 
skills, and problems with social perception (Barton and North, 2004; Kayl and 
Moore, 2000; Eliason, 1986). Such deficits could also be the result from the 
inability to learn and retain appropriate social cues. Nf1+/- mice show normal 
preference for social interaction (see Figure 9), and display intact short-term 
social learning (see Figure 10a). However, when presented with a novel mouse 
 108 
 
and the same “familiar” mouse 24 hours later, Nf1+/- mice are unable to 
differentiate between the novel mouse and the “familiar” mouse, while WT mice 
continue to show robust long-term social learning (see Figure 10b). Therefore, 
these findings suggest that the social profile of the Nf1+/- mouse model is largely 
consistent with the social abnormalities seen in NF1 patients. Therefore, the 
identification of the mechanism(s) responsible for these social learning deficits 
seen in Nf1+/- mice may provide important information to improve the treatment 
options for these NF1-related social learning problems.  
While human studies have found a moderately increased risk for the 
development of anxiety and depression in patients diagnosed with NF1 
(Samuelsson and Riccardi, 1989; Zoller and Rembeck, 1999; Johnson et al, 
1999), Nf1+/- mice displayed no differences in anxiety-like behavior, as measured 
using the elevated plus maze and in the open field test (see Figures 11-12). 
Furthermore, WT and Nf1+/- mice displayed no differences in their percent time 
immobile during two trials that were separated by 24 hours in the forced swim 
test (see Figure 13). Therefore, these experiments were unable to capture 
effects of the Nf1+/- genotype on rodent behavioral measures that are associated 
with anxiety and depression in humans. However, anxiety and depression are 
complex psychiatric disorders influenced by multiple factors including the 
genetics, the environment, and gene x environment interactions (Nandi et al, 
2009). 
In addition to anxiety-like behavior, the EPM was utilized to test one-trial 
learning as defined by the classic reduction in open arm time and open arm 
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entries commonly observed when rodents are re-tested in the EPM on day 2 
(Roy et al, 2009). Nf1+/- mice displayed no differences in one-trial learning (see 
Figure 11). These findings suggest that the Nf1+/- genotype does not globally 
affect learning / memory, but leaves some forms of learning / memory intact. 
However, the motivations that underlie one-trial learning in the EPM are not 
clearly defined in the literature, and may result from avoidance or fear-based 
learning or a reduction in open arm novelty. These motivations ultimately result in 
a shift in behavior from the open arms toward the closed arms of the EPM on day 
2 (Roy et al, 2009).   
 
 
B. Loss of Pak1 rescues abnormalities in social learning and MAPK 
signal transduction seen in Nf1+/- mice 
PAK1 has been identified as a critical RAS-mediated effector that has 
been shown to regulate the intracellular signal transduction of PI3K and MAPK, 
and has been implicated in numerous processes involved in CNS function, 
including synaptic plasticity (see Kreis and Barnier, 2009 for review). Previous 
studies demonstrate that the loss of Pak1 normalizes the MAPK hyperactivation 
seen in haploinsufficient mast cells, and the co-deletion of Pak1 in Nf1+/- mice 
restores gain-in-function phenotypes in mast cells (McDaniel et al, 2008). The 
same genetic intercross strategy was employed to determine whether the co-
deletion of Pak1 in Nf1+/- mice would restore the long-term social learning / 
memory deficits previously seen in Nf1+/- mice. 
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Similar to findings in experiment 1, no differences were observed between 
genotypes in preference for social interaction (see Figure 15) or short-term 
social learning (see Figure 16a). However, unlike the Nf1+/- genotype, both Nf1+/- 
/ Pak1-/- and Pak1-/- mice showed significant preference for social novelty even 
after 24 hours, indicating that Nf1+/- / Pak1-/- mice are now able to retain and 
discriminate between familiar and unfamiliar social cues following a 24 hour 
delay (see Figure 16b). Therefore, the findings from experiment 2 demonstrate 
that the abnormalities in social learning seen in Nf1+/- mice can be rescued by the 
co-deletion of Pak1 gene. Similar to the findings associated with the Nf1+/- 
genotype, the loss of Pak1 had no effect on anxiety-like behavior (see Figure 
17). Interestingly, the loss of Pak1 was associated with decreased depression-
associated immobility in mice (see Figure 18). 
While the co-deletion of Pak1 has been shown to restore the Nf1+/--related 
hyperactivation of MAPK in mast cells (McDaniel et al, 2008), the effects of Nf1 
and Pak1 expression on MAPK activation were not yet characterized in neuronal 
cultures from the frontal cortex. We demonstrate that, in the presence of SCF, 
Nf1+/- neurons cultured from the frontal cortex show a significantly greater 
increase in active ERK1/2, as compared to WT, and the co-deletion of Pak1 
normalizes this hyperactivation of ERK1/2 to levels that are consistent with WT 
(see Figure 20). Therefore, the hyperactivation in MAPK signaling associated 
with Nf1+/- genotype is regulated in a PAK1-dependent manner in the CNS, and 
thereby, may contribute to the deficits in long-term social learning / memory seen 
in Nf1+/- mice (Figure 23).  
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Figure 23. Illustration that depicts a hypothetical mechanism(s) explaining 
how PAK1 may interact with MAPK to restore abnormalities in learning and 
memory seen in Nf1+/- mice. Neurofibromin negatively regulates RAS GTPase 
activation, and is, in part, responsible for the propagation of the classical MAPK 
and PI3K signaling cascades. In addition to the Nf1+/--related hyperactivation of 
RAS-dependent pathways, Nf1+/- genotype affects cytoskeletal remodeling, 
cellular proliferation, synaptic plasticity and learning and memory. Our findings 
suggest that co-deletion of Pak1 gene in Nf1+/- cells may restore these functions 
by normalizing the hyperactivation of MAPK. 
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The RAS/MAPK signaling cascade is mediated through the activation of 
receptor tyrosine kinase (RTK) by multiple growth factors including nerve growth 
factor (NGF), brain derived neurotophic factor (BDNF), stem cell factor (SCF), 
and many others (Campbell et al, 1998). In addition, SCF/c-kit are abundantly 
expressed in neurons and glia in the CNS of mice (Zhang and Fedoroff, 1997). In 
vitro studies show that the administration of recombinant SCF to astroglia leads 
to the up-regulation of other growth factors including NGF and BDNF (Zhang and 
Fedoroff, 1997). Because the Pak1-/- genotype did not display significant MAPK 
activation in response to SCF application, these results may indicate that MAPK 
activation associated with SCF/c-kit signaling is primarily mediated in a PAK1-
dependent manner (see Figure 20). Due to its role in MAPK signaling in the 
PFC, SCF/c-kit and other growth factors likely play an integral role in the 
regulation of long-term social learning in mice and other processes in the CNS 
that are mediated in a PAK1-dependent manner. 
 
C. Nf1 and Pak1 affect inhibitory synaptic currents (IPSCs) in BLA 
glutamatergic projection neurons in mice 
Previous studies in Nf1+/--hippocampal neurons found increases in the 
frequency of inhibitory synaptic currents under periods of high-frequency 
stimulation (Cui et al, 2008). While no differences were observed in Nf1+/- mice in 
either sIPSC or mIPSC amplitude, Nf1+/- mice showed significant increases in 
both sIPSC and mIPSC frequency in glutamatergic projection neurons isolated 
from the BLA, as compared to WT (see Figure 21). The administration of a 
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GABAA antagonist (SR 95531 hydrobromide) and a GABAB antagonist (CGP 
52432) block the mIPSCs, consistent with GABA-mediated inhibition. In the BLA, 
glutamatergic projection neurons are regulated by excitatory input that is largely 
sensory information and inhibitory input from local GABAergic interneurons (see 
Figure 4). Therefore, the increases in IPSCs frequency observed in 
glutamatergic projection neurons in the BLA seen Nf1+/- mice could potentially 
result from increased presynaptic GABA release from inhibitory interneurons 
localized to the BLA.  
Next, we determined whether the genetic inactivation of Pak1 in Nf1+/- 
(Nf1+/-/ Pak1-/-) mice would restore the increases in inhibitory synaptic currents 
seen in Nf1+/- mice. While no differences were detected in sIPSC or mIPSC 
amplitude, we found that the co-deletion of Pak1 normalized the increases in 
sIPSC and mIPSC frequency, as compared to Nf1+/- mice (see Figure 22). These 
results demonstrate that increases in IPSCs in BLA glutamatergic projection 
neurons seen in Nf1+/- mice are corrected in the Nf1+/- / Pak1-/- mice. Abnormal 
tonic inhibition in the BLA can cause communication problems with PFC that can 
lead to inappropriate emotional assessment and assignment of saliency to social 
cues (see Bachevalier and Malkova 2006 for review). Ultimately, the balance of 
excitation and inhibition can have important effects on functions of the BLA, 
including social and emotion learning.  
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D. Role of Nf1 and Pak1 genes in the regulation of protein 
expression in the PFC and BLA 
The prefrontal-amygdala circuit defines a primary processing center for 
emotional aspects of social response, and its dysregulation can have profound 
effects on social function in humans and rodents. Mass spectrometry was used 
to screen for differences in proteins expressed in the PFC and BLA associated 
with the Nf1+/- genotype and were restored by the co-deletion of Pak1 gene in 
Nf1+/- mice. Proteins were selected based on the following criteria: (1) significant 
differences between WT vs. Nf1+/- group, (2) significant differences between 
Nf1+/- vs. Nf1+/- / Pak1-/- group, and (3) were consistent with a rescue (see Tables 
1-2). The resulting proteins were then characterized based on their known 
biology and their relevance to NF1-related phenotypes utilizing resources from 
National Center for Biotechnology Information [www.ncbi.nlm.nih.gov]. 
 
1. Proteins identified in the PFC 
In the PFC, the co-deletion of Pak1 gene rescues differences in protein 
expression seen in Nf1+/- mice that perform multiple cellular functions including 
the regulation of RNA transcription, protein modification and packaging, 
cytoskeletal dynamics, vesicular fusion, and neurotransmission. Therefore, the 
proteomics findings in this dissertation indicate that the mechanism(s) involved in 
the PAK1-dependent rescue of the deficits in long-term social learning likely are 
complex, but affect a finite number of proteins that mediate specific cellular 
processes. Additionally, these proteomics findings reveal a more robust effect of 
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the Pak1 gene co-deletion in the PFC identifying twenty one proteins, while only 
one protein exhibited an expression profile consistent with a rescue in the BLA. 
 
a. Proteins involved in the regulation of DNA 
Due to its role as a negative regulator of RAS activation, neurofibromin 
acts as a key regulator in signal transduction from the cell membrane to the 
nucleus (see Le and Parada, 2007 for review). DNA represents the cornerstone 
of the cellular function by providing the genomic code for RNAs and their 
respective proteins, and dysregulation in DNA structure and function can lead to 
important effects on the CNS. Histones play a central role in transcription 
regulation, DNA repair, DNA replication and chromosomal stability. In the PFC, 
both H2A2B and NUCL are expressed at higher levels in Nf1+/- mice. Histone 
H2A type 2-B or H2A2B is a core component of nucleosomes, proteins that wrap 
and compact DNA into chromatin, limiting DNA accessibility to the cellular 
machineries which require DNA as a template (Bergink et al, 2006). Nucleolin or 
NUCL is histone chaperone protein associated with intranucleolar chromatin and 
pre-ribosomal particles. NUCL induces chromatin decondensation by binding to 
histone H1, thereby, NUCL increases DNA accessibility needed for RNA 
transcriptional elongation (see Storck et al, 2007 for review). The upregulation of 
H2A2B and NUCL in Nf1+/- mice may alter the accessibility of DNA broadly 
affecting gene expression.  
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b. Proteins involved in the regulation of RNA 
RNA transcription and its subsequent modification into mRNA represent 
core cellular processes. Both HNRH1 and CAPRI are expressed at higher levels 
in the PFC of Nf1+/- mice. Heterogeneous nuclear ribonucleoprotein H or HNRH1 
is localized to the nucleoplasm in the nucleus, and is a component of the 
heterogeneous nuclear ribonucleoprotein (hnRNP) complexes which provide the 
substrate for the processing events that pre-mRNAs undergo before becoming 
functional, translatable mRNAs in the cytoplasm (Paul et al, 2006). Additionally, 
Caprin-1 or CAPRI regulates the transport and translation of mRNAs of proteins, 
and has been shown to mediate cellular proliferation (Wang et al, 2005). In 
neuronal cells, CAPRI directly binds to mRNAs associated with RNA granules, 
including BDNF, CAMK2A, CREB1, MAP2, NTRK2, GRIN1, KPNB1 mRNAs. 
Through processing and transport of mRNA, HNRH1 and CAPRI affect the 
expression of multiple proteins involved in the regulation of DNA transcription, 
cellular proliferation and cytoskeletal dynamics in the CNS.  
 
c. Proteins involved in the regulation of protein translation 
The endoplasmic reticulum (ER) is the site of protein synthesis, and the 
rough ER is responsible for transporting the newly synthesized proteins to the 
Golgi apparatus, the cellular site for protein modifications. Nascent polypeptide-
associated complex subunit alpha or NACAM prevents inappropriate targeting of 
non-secretory polypeptides to the ER by binding to nascent polypeptide chains 
as they emerge from the ribosome and blocks their interaction with the signal 
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recognition particle (George et al, 2002). NACAM also reduces the inherent 
affinity of ribosomes for protein translocation sites in the ER membrane. Adapter-
related protein complex 1 subunit beta-1 or AP1B1 plays a role in protein sorting 
in the Golgi apparatus by mediating both the recruitment of clathrin to 
membranes and the recognition of sorting signals within the cytosolic tails of 
transmembrane cargo molecules (Santambrogio et al, 2005). In the PFC, 
NACAM is expressed at lower levels in Nf1+/- mice, while AP1B1 is expressed at 
higher levels. Additionally, Clathrin light chain B or CLCB is expressed at higher 
levels in the PFC of Nf1+/- mice. CLCB is the major protein localized to the 
polyhedral coat of vesicles (Brodsky et al, 1987), and has been associated with 
schizophrenia in humans (Vercauteren et al, 2007). Thus, NACAM, AP1B1 and 
CLCB proteins are involved in the regulation of protein modification and secretion 
in the ER and Golgi apparatus.  
 
d. Proteins involved in F-actin and microtubule dynamics 
In the developing forebrain, cytoskeletal dynamics regulates cellular 
processes involved in neuronal polarization (i.e., neuronal migration, axon 
specification), dendritic spine morphology, and vesicular release (see Arimura 
and Kaibuchi for review). While the mechanisms that contribute to these 
cytoskeletal changes are still largely uncharacterized, the regulation of 
filamentous actin (F-actin) and microtubule dynamics are critical for these cellular 
processes associated with cytoskeletal dynamics. Consistent with disruption in 
cytoskeletal dynamics, Brown et al (2010) found that hippocampal neurons 
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cultured from Nf1+/- mouse embryos show reduced neurite lengths and growth 
cone areas. In addition, F-actin is abundantly expressed in the dendritic spine, 
the postsynaptic structure in neurons. F-actin dynamics is also involved in the 
enlargement of vesicular pool size and increases in vesicle-fusion probability 
(see Zucker, 1989 for review). Pharmacological experiments further demonstrate 
that interfering with F-actin inhibits long-term potentiation (LTP) in hippocampal 
neurons, a mechanism that is critical for synaptic plasticity and memory formation 
(Kim and Lisman, 1999). 
In the PFC, three proteins were identified that are involved in the 
regulation of F-actin dynamics. Alpha-actin-1 or ACTS is expressed at higher 
levels in the PFC of Nf1+/- mice. ACTS is ubiquitously expressed in eukaryotic 
cells. The polymerization of globular actin (G-actin) leads to the formation of 
filamentous actin (F-actin) in the form of a two-stranded helix. F-actin-capping 
protein subunit alpha-2 or CAZA2 is expressed at lower levels in the PFC of 
Nf1+/- mice. F-actin-capping proteins bind in a Ca2+-independent manner to the 
fast growing ends of actin filaments (barbed end), thereby blocking the exchange 
of subunits at these ends. Drebrin or DREB is expressed at higher levels in the 
PFC of Nf1+/- mice. DREB directly binds to F-actin. DREB is involved in 
organizing the dendritic pool of actin, and coordinates F-actin-microtubule 
interactions that mediate neuronal polarity and motility including neurite formation 
and the regulation of growth cones (Geraldo et al, 2008). Thereby, DREB 
regulates both cell shape and plasticity, and has been associated with 
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Alzheimer's disease and Down syndrome (Harigaya et al, 1996; Dun and Chilton, 
2010). 
In the CNS, PAK1 is essential for cytoskeletal dynamics by acting in a 
kinase-dependent manner to regulate F-actin formation and microtubule 
stabilization (see Jacobs et al, 2007 for review; Figure 24). PAK1 has been 
shown to regulate LIM kinase activity, leading to the destabilization cofilin and the 
inactivation and aggregation of F-actin fibers (Ishibashi, 2008). The 
overexpression of PAK1 leads to increases in cellular motility and actin 
polymerization, while the expression of dominant negative PAK1 results in 
decreases in migration and organized actin structures (Sells et al, 1999). 
Through its interaction of LIMK and cofilin, PAK1, thereby, mediates cytoskeletal 
dynamics including F-actin assembly and vesicular transport (Vadlamudi et al, 
2002). It has been shown that disruption of cortical F-actin can evoke vesicle 
translocation, thereby liberating large dense core vessicles bound to F-actin 
(Rose et al, 2001; Neco et al, 2003). In addition, MAPK signaling regulates F-
actin disassembly, thereby modulating vesicular release. For example, the 
inhibition of MAPK signaling blocks the effect of activity dependent potentials 
suppressing the vesicular release (Park et al, 2006). In neurons, MAPK activation 
in a calcium dependent manner leads to phosphorylation of synapsin I, which 
causes F-actin disassembly and subsequent translocation of vesicles (Yamagata 
et al, 2002).  
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Figure 24. Model illustrating the role of Pak1 in the regulation of F-actin and 
microtubules. The specification of an axon and subsequent outgrowth of axons 
and dendrites require the dynamic turnover of F-actin and microtubules. PAK1 
and its downstream targets, in part, regulate F-actin growth / severing and 
microtubule stabilization / destabilization. Pak1 activates LIMK-1, therby, 
inhibiting cofilin activation. Pak1 also mediates microtubule dynamics through the 
phosphorylation and inactivation of the microtubule-destabilizing protein 
stathmin. 
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In addition to the regulation of F-actin, PAK1 also mediates microtubule 
dynamics through the phosphorylation and inactivation of the microtubule-
destabilizing protein stathmin (Daub et al, 2001; see Figure 24). Three proteins 
were identified that are associated with dysregulation in microtubule dynamics. 
For instance, microtubule-associated protein 1A or MAP1A is expressed at 
higher levels in the PFC of Nf1+/- mice. MAP1A is a structural protein involved in 
the filamentous cross-bridging between microtubules and other skeletal elements 
(Pedrotti et al, 1994). Dynein light chain 2 (DYL2) is expressed at lower levels in 
the PFC of Nf1+/- mice. DYL2 is involved in some aspects of dynein-related 
intracellular transport and motility, and may play a role in changing or maintaining 
the spatial distribution of cytoskeletal structures localized to cytoplasm. Dynamin-
1 or DYN1 is expressed at lower levels in the PFC of Nf1+/- mice. DYN1 is a 
microtubule-associated force-producing protein that is involved in producing 
microtubule bundles. DYN1 is able to bind and hydrolyze GTP, and interacts with 
soluble N-ethylmaleimide-sensitive factor attachment protein receptors (Gorini et 
al, 2010). DYN1 regulates receptor-mediated endocytosis associated with 
vesicular trafficking, has been associated with schizophrenia and bipolar disorder 
(Martins-de-Souza et al, 2009; Gray et al, 2010).  
 
e. Proteins associated with vesicular fusion 
Following protein modification, finished protein products, or glycoproteins, 
are transported in vesicles (i.e., vesicular trafficking) to the cellular membrane. 
Synaptic vesicles then bind to receptors on the surface of the membrane, and the 
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glycoproteins are excreted from the neuron through vesicular translocation 
(Südhof et al, 1993). Membrane fusion in neurons is Ca2+ dependent process 
and involves the interaction of synaptic vesicle proteins, plasma membrane 
proteins, and cytoplasmic proteins (Söllner et al, 1993). Neurons contain large 
dense-core vesicles and small synaptic vesicles that are responsible for 
secretion of neuropeptides or hormones and classical neurotransmitters, 
respectively. Both large dense-core vesicles and small synaptic vesicles show 
activity dependent release (Shakiryanova et al, 2005). 
Thy-1 membrane glycoprotein or THY1 is expressed at higher levels in the 
PFC of Nf1+/- mice. THY1 is a component of both large dense-core and small 
clear vesicles in the CNS, and plays an important role in the regulation of 
vesicular release of neurotransmitter and neuromodulators at the synapse. THY1 
is expressed by neuronal cells in culture (Wilkerson and Touster, 1993). THY1 
mediates signal transduction by increasing intracellular Ca2+ levels (Barboni et al, 
1991) and stimulating tyrosine phosphorylation (Hsi et al, 1989). Thy-1 null mice 
show selective social learning deficits in the social transmission of food 
preference test (Mayeux-Portas et al, 2000). Additionally, Thy-1-/- mice exhibit 
excessive GABAergic inhibition and deficits in LTP in the dentate gyrus (Hollrigel 
et al, 1998; Nosten-Bertrand et al, 1996). These deficits in social learning can be 
restored by the administration of a GABAA receptor antagonist (Mayeux-Portas et 
al, 2000). 
Syntaxin binding protein 1 or STXBP1 is detected at lower levels in the 
PFC of Nf1+/- mice. STXBP1 is involved in the regulation of SNARE-dependent 
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membrane fusion necessary for membrane expansion during neurite formation 
(Steiner et al, 2002). STXBP1 is a presynaptic protein that binds to the closed 
conformation of syntaxin, and thus inhibits its assembly into the SNARE complex 
(Yang et al, 2000) Release from STXBP1 and activation of the open 
conformation of syntaxin is key to synaptic membrane fusion and the release of 
neurotransmitters into the synaptic gap (Mitchell et al, 2005). Additionally, 
syntaxin has been shown to promote neurite outgrowth in cell culture (Steiner et 
al, 2002). Through its interaction with syntaxin, STXB1 participates in the 
regulation of synaptic vesicle docking and fusion, possibly through interaction 
with GTP-binding proteins (Mitchell et al, 2005), and has been associated with 
increased risk for schizophrenia and bipolar disorder (Vercauteren et al, 2007; 
Behan et al, 2009).  
Detected at higher levels in the PFC, limbic system-associated membrane 
protein or LSAMP is a glycoprotein that mediates selective neuronal growth and 
axon targeting by through the guidance of developing axons and the remodeling 
of mature circuits in the limbic system. LSAMP is expressed on the surface of 
somata and dendrites of neurons in cortical and subcortical regions (Horton and 
Levitt, 1988; Zacco et al, 1990). LSAMP can enhance or inhibit neurite outgrowth 
depending on the neuronal population (Pimenta and Levitt, 2004). While basic 
neuroanatomical organization and sensory and motor development appear to be 
normal, Lsamp-/- mice display a heightened reactivity to novelty and hyperactivity 
in a novel arena indicating a possibly maladaptive response to novel 
environmental stressors (Catania et al, 2008). Additionally, LSAMP has been 
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implicated in schizophrenia, mood disorders, and an increased risk for suicide 
(Behan et al, 2009; Must et al, 2008).  
 
f. Proteins associated with myelination 
In the central nervous system, PAK1 is enriched in oligodendrocytes or 
glial cells that provide a supporting role for neurons and produce the myelin 
sheath insulating axons (Dharmawardhane et al, 1997). Myelin allows for the 
efficient conduction of action potentials down the axon by reducing ion leakage 
and decreasing the capacitance of the cell membrane. Nf1+/- mice show 
increases in the expression of MBPs in the PFC. Myelin basic proteins or MBP 
isoforms (isoform 4-isoform 13) are the most abundant protein components of the 
myelin membrane in the CNS. MBPs play an essential role in both the formation 
and stabilization of the myelin sheath. Human studies have found decreased 
expression of MBPs in temporal lobe of schizophrenics (Martins-de-Souza et al, 
2009) 
 
g. Proteins involved in neurotransmission 
Two proteins were identified in the PFC that may modulate 
neurotransmission. Glutamate dehydrogenase 1 or DHE is expressed at lower 
levels in the PFC of Nf1+/- mice. DHE is localized to the mitochondrial matrix and 
may be involved in learning and memory by increasing the turnover of the 
excitatory neurotransmitter glutamate. DHE3 is subject to allosteric regulation in 
that it is activated by ADP by occupying the NADH binding site, and inhibited by 
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GTP. Bao et al (2009) generated a transgenic mouse model with increased 
expression of DHE that exhibits a life-long excess of synaptic glutamate release 
in the CNS. These transgenic mice display neuronal losses in select brain 
regions (e.g., the CA1 of the hippocampus) and decreases in LTP and in spine 
density in dendrites of CA1 neurons. These findings demonstrate that DHE 
dysregulation can lead to synaptic changes in cellular processes associated with 
learning and memory. Calbindin 1 or CALB1 is expressed at higher levels in the 
PFC of Nf1+/- mice. CALB1 buffers cytosolic Ca2+ levels, and may stimulate 
membrane Ca2+-ATPase. It has been proposed that dysregulation of calcium 
homeostasis may be an important factor in the pathogenesis of Parkinson‟s 
disease and that calcium buffers such as CALB1 may be neuroprotective (Chan 
et al, 2009; Mattson, 2007). Therefore, dysregulation in DHE and CALB1 seen in 
Nf1+/- mice may lead to changes in glutamatergic neurotransmission and cytosolic 
Ca2+ levels in the CNS, respectively.  
 
h. Other proteins involved in cellular function  
Alpha-enolase or ENOA is expressed at lower levels in the PFC of Nf1+/- 
mice. ENOA is a multifunctional enzyme that regulates multiple cellular 
processes including glycolysis, cell growth, hypoxia tolerance and allergic 
responses. L-lactate dehydrogenase A chain or LDHA is expressed at lower 
levels in the PFC of Nf1+/- mice. LDHA is involved in the fermentation of pyruvate 
to lactate. These proteins mediate pathways involved in energy production that 
are associated with the metabolism of glucose. 
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2. Protein identified in the BLA 
In the basolateral amygdala, disintegrin and metalloproteinase domain-
containing protein 22 or ADAM22 is expressed at lower levels in Nf1+/- mice. 
ADAM22 is a ligand for integrin that regulates cell adhesion and spreading and 
inhibits cellular proliferation. ADAM22 (a receptor) and its ligand LGI1 are widely 
involved in the regulation of neuronal development and synaptic functions (see 
Han and Kim, 2008 for review). The LGI1/ADAM22 complex is thought to interact 
with and stabilize the AMPAR/stargazing complex on the PSD-95 scaffolding 
platform anchoring the AMPAR/stargazin complex at postsynaptic sites (Fukata 
et al, 2010). PSD-95 expression mediates synaptogenesis, and the development 
of excitatory verses inhibitory synapses (see Cline, 2005 for review). 
Furthermore, LGI1 has been shown to bind to Kv1.1, a presynaptic voltage-gated 
potassium channel subunit (Schulte et al, 2006). Mice lacking ADAM22 display 
reduced body weight, hypomyelination of peripheral nerves, and ataxia, and die 
before postnatal day 20 as a result of multiple seizures (Sagane et al, 2005). 
Thereby, ADAM22 plays an integral role in the regulation of neurotransmission 
and protein trafficking, and has been implicated in the development of epilepsy in 
humans (Diani et al, 2008). 
 
D. The NF1 mouse model: the genetics, biochemistry, cell biology 
and behavior 
The impact of scientific research using animal models is largely dependent 
on the relevance of the animal model to the human condition. By utilizing 
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homologous recombination strategies to selectively knock-out the Nf1 gene in 
mice (Jacks et al, 1994), the Nf1+/- mouse model closely mimics the genetic 
determinant that underlies the development of NF1 in humans. Likewise, the 
biochemical and cellular processes mediated by neurofibromin (i.e., RAS, MAPK, 
PAK1, etc.) are conserved in the Nf1+/- mouse model. Because the NF1 condition 
is a simple autosomal dominant disorder, the Nf1+/- mouse closely resembles the 
biological dysfunctions that are seen in the NF1 condition in humans. Therefore, 
the construct validity associated with the Nf1+/- mouse model and its relationship 
to NF1 in humans is well-defined. To date, many of the features associated with 
the NF1 condition in humans have been detected in the Nf1+/- mouse model 
including learning and memory deficits (Silva et al, 1997). Consistent with the 
social problems seen in NF1 patients, this dissertation is the first to provide 
evidence that the Nf1+/- mouse model displays significant disruption in social 
learning. Therefore, these novel findings strengthen the face validity of the Nf1+/- 
mouse model. 
The NF1 gene functions as a classic tumor suppressor gene in humans 
(Colman et al, 1995). Similar to humans, the complete loss of the Nf1 gene leads 
to tumorigenesis in chimeric mice partially composed of Nf1-/- cells providing 
further face validity for the Nf1+/- mouse model (Chichowski et al, 1999).  
However, the disruptions in cognition, learning and memory, and social function 
associated with the NF1 gene deletion are independent of tumor disposition in 
humans (Moore et al, 1994) and mice (Silva et al, 1997). Therefore, the genetic 
mechanism that underlies disruption in CNS function is Nf1 haploinsufficiency or 
 128 
 
a gene dosing effect leading to incomplete or partial dominance. In the periphery, 
Nf1 haploinsufficiency has been associated with enhanced MAPK activity and 
increases in SCF-mediated mast cell proliferation, survival, and colony formation 
(Ingram et al, 2000).  
In the CNS, Nf1 haploinsufficiency would be consistent with the high level 
of variability that is associated with NF1-related learning disabilities, attention and 
social function (Hofman et al, 1994; North et al, 1997; Dilts et al, 1996; Brewer et 
al, 1997; Johnson et al, 1999; Kayl and Moore 2000; Noll et al, 2007). In addition 
to previous studies in the CNS, this dissertation identifies disruptions in SCF-
mediated hyperactivation of MAPK in Nf1+/- neurons cultured from the PFC and 
observed increases in IPSCs in glutamatergic projection neurons in BLA. 
Thereby, these findings are consistent with Nf1 haploinsufficiency in CNS 
neurons. Similar to the biologic and cellular interactions in the tumor 
microenvironment (Staser et al, 2010), Nf1 haploinsufficiency may redefine the 
tripartite synapse in multiple brain regions resulting in disruption in CNS function, 
and ultimately abnormalities in CNS processes (e.g., learning and memory). 
However, the Nf1+/- microenvironment in the CNS defined by interactions 
between pre-synaptic neurons, post-synaptic neurons, and glia remains to be 
elucidated. 
While much progress has been made to identify the mechanism(s) that 
underlie the learning disabilities observed in Nf1+/- mouse model, the 
mechanism(s) is not yet clearly established. Previous studies have focused on 
processes involved in hippocampal-based learning, and have implicated 
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increases in RAS activation and MAPK signaling, and have found increases in 
GABA-mediated inhibition and deficits in LTP in Nf1+/- mice (Silva et al, 1997; 
Costa et al, 2002; Li et al, 2005). Thereby, MAPK hyperactivation and increases 
in GABA-mediated inhibition have been proposed as potential mechanisms 
underlying hippocampal-based learning abnormalities (Shilyansky et al, 2010). 
To further characterize the mechanism(s) underlying the disruptions in social 
learning, this dissertation focused on the prefrontal-amygdala circuit. Similar to 
previous findings in the hippocampus, this dissertation demonstrates that the 
Nf1+/- mouse model displays MAPK hyperactivation in the PFC and increases in 
GABA-mediated inhibition in the BLA. This dissertation further demonstrates 
these disruptions in social learning, MAPK signaling and IPSCs are mediated in a 
Pak1-dependent manner. Due to its activation of PAK1 and MAPK, SCF/c-kit 
signaling represents a potential mechanism of interest to learning abnormalities 
seen in Nf1-deficient mice.  
Expression profiling strategies have been implemented to identify 
candidate genes and/or candidate proteins that contribute to endophenotypes 
associated with disease. For this purpose, mass spectrometry was conducted to 
identify protein expression differences associated with the Nf1+/- genotype in 
mice that were rescued by the co-deletion of Pak1. Because the disruption in 
long-term social learning/memory is mediated in a Pak1-dependent manner, this 
dissertation identified proteins with expression profiles that are consistent with a 
Pak1-dependent rescue. In the PFC, proteins involved in the regulation of F-actin 
and microtubule dynamics represent targets of interest due to their close 
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association with PAK1 and MAPK signaling in the regulation of cytoskeletal 
dynamics and vesicular release (see Kreis and Barnier, 2009 for review). 
Consistent with disruption in cytoskeletal dynamics (i.e., F-actin growth, 
microtubule stabilization), a reduction in neurite lengths and growth cone areas 
have been documented in hippocampal neurons cultured from Nf1+/- mouse 
embryos (Brown et al, 2010). LSAMP and STXB1, and DREB have been 
implicated in neurite formation (Pimenta and Levitt, 2004; Steiner et al, 2002; 
Geraldo et al, 2008). In the BLA, ADAM22 provides an interesting protein 
candidate due to its role in the regulation of AMPA receptors by stabilizing the 
AMPAR/stargazing complex on the PSD-95 scaffolding platform and anchoring 
the AMPAR/stargazin complex at postsynaptic sites (Fukata et al, 2010). 
Therefore, disruption in the amygdala-prefrontal circuit may contribute to 
abnormalities in social learning seen in the Nf1+/- mouse model. 
 
E. NF1, the amygdala, and autism 
Autism spectrum disorders comprise a heterogeneous group of conditions 
characterized by developmental abnormalities in cognition, communication, and 
social function (see Pardo and Eberhart, 2007 for review). NF1 shows a 
dramatically increased frequency in autistic patients with an estimated 
prevalence of 1.2% (Martin et al, 2007). Furthermore, the chromosomal region 
harboring the NF1 locus has been linked to autism (IMGSAC, 2001; Yonan et al, 
2003), and several studies have detected a significant association between the 
NF1 locus and autism in humans (Mbarek  et al, 1999; Mouridsen et al, 1992; 
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Marui et al, 2004). While the relationship between autism and NF1 is not yet well-
established, the NF1 gene deletion may represent an important etiological 
variable for autistic development. 
NF1 children often show problems with social interaction and social 
perception in that they inappropriately perceive and interpret social cues, 
including facial expressions, body gestures, and tone of voice (Eliason, 1986). 
The present dissertation demonstrates that Nf1+/- mice show deficits in social 
learning that are associated with disruption in the prefrontal-amygdala circuit. 
Likewise, subjects with autism and Asperger‟s syndrome display symptoms of 
prosopagnosia or marked impairments in the processing of facial expressions 
(Davies et al, 1994; Schultz et al, 2000). Interestingly, human subjects with 
amygdala damage also have difficulty with facial recognition tasks (Adolphs et al, 
1994; Young et al, 1995; Adolphs et al, 1998). In autistic patients, disruption in 
face processing is associated with abnormalities in structure and functional 
activation of the amygdala (Pierce et al, 2001). In addition, a postmortem study 
found abnormalities in neuronal structure (i.e., neuronal size, cell packing 
density) in various sub-nuclei of the amygdala (Kemper and Bauman, 1998). 
Therefore, “social learning” may be an important variable to consider in 
examining the relationship between the NF1 gene deletion, NF1-related social 
deficits, and autism. 
Several brain regions have been implicated in autistic development such 
as the cerebellum, amygdala, hippocampus, and PFC (Courchesne et al, 1988; 
Sweeten et al, 2002). In particular, the amygdala represents a region of interest 
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due to its role in the mediation of social and aggressive behaviors (see Aggleton, 
1992 for review). For instance, the bilateral removal of the amygdala, 
hippocampus and cortical regions in monkeys that are six months of age present 
autistic-like features, including unexpressive faces, very little eye contact, 
stereotypic behaviors, and self-directed activity (see Bachevalier, 1994 for 
review; Bachevalier, 1996). Additionally, several structural neuroimaging studies 
have shown abnormalities in the sizes of the amygdala, hippocampus and other 
limbic areas in patients with autism, as compared to controls (Kates et al, 1998; 
Aylward et al, 1999; Abell et al, 1999). Other imaging studies using MRI 
techniques found an enlargement in cortical regions in autistic patients relative to 
controls (Piven et al, 1995; Piven et al, 1996). Because the Nf1+/- mouse model 
displays social learning abnormalities, the genetic, molecular, 
electrophysiological and behavioral findings presented in this dissertation may 
help identify novel targets for the treatment for social deficits in NF1 patients and 
potentially NF1-related autism. 
 
F. Summary and future directions 
The present dissertation first screened the Nf1+/- mouse model in order to 
assess aspects of social and emotional learning. We found selective deficits in 
long-term social learning in Nf1+/- mice, while we detected no differences in their 
preference for social interaction, short-term social learning, anxiety, one-trial 
learning (EPM) or depression-associated response. The deficits in social learning 
seen in the Nf1+/- mouse model are consistent with social problems seen in NF1 
patients. Given that patients with autism have an increased incidence of NF1, the 
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NF1 gene has been identified as a potential risk factor for some forms of autism 
(see Zafeiriou et al, 2007 for review). In the Nf1+/- mouse model, behavioral 
studies could be conducted to further characterize social learning and social 
communication including the social transmission of food preference test and 
ultrasonic vocalization test, respectively.  
The social transmission of food preference test measures the ability of 
mice to obtain meaningful information associated with food preference (non-
social cues) through social interactions with a cage-mate (Wrenn, 2004). To 
assess the development of social communication in rodents, ultrasonic 
vocalizations induced by their separation from their dam are measured in mouse 
pups (Scattoni et al, 2009). Low levels of separation-induced of infant 
vocalization (50-80 kHz) and low levels of retrieval by the dam would be 
indicative of a failure to respond appropriately to socially meaningful stimuli. 
Likewise, disruption in ultrasonic vocalization (e.g., fewer ultrasonic vocalization 
calls or less quieting by mouse pups; failure to respond by dam) would be 
consistent with abnormal development of rodent communication. 
This dissertation demonstrates a SCF-mediated hyperactivation of MAPK 
signaling in neurons cultured from the PFC of Nf1+/- mouse pups that are 
mediated in a Pak1-dependent manner. In addition to MAPK signaling (Beeser et 
al, 2005; Park et al, 2007), PAK1 regulates LIM kinase activity leading to the 
destabilization cofilin and the polymerization F-actin (Ishibashi, 2008). Future 
studies utilizing pharmacological manipulation strategies to selectively target 
MAPK and/or LIMK signaling could better characterize the signaling pathway(s) 
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that regulates social learning deficits seen in Nf1+/- mice. Additionally, 
electrophysiological studies could be conducted to characterize how 
pharmacological inhibition of MAPK and/or LIMK affect IPSCs observed in 
glutamatergic projection neurons in the BLA. Thereby, these future studies would 
determine the down-stream pathways that underlie the Pak1-dependent rescue 
of social learning and IPSCs seen in Nf1+/- mice.  
Using the whole-cell patch clamp, this dissertation demonstrates 
increases in the frequency of IPSCs measured in glutamatergic projection 
neurons in the BLA of Nf1+/- mice. The administration of a GABAA antagonist (SR 
95531 hydrobromide) and a GABAB antagonist (CGP 52432) block the IPSCs; 
therefore, these IPSCs are consistent with GABA-mediated inhibition. However, it 
is not known whether these increases in IPSC frequency are a product of 
increases in presynaptic GABA release from inhibitory interneurons localized to 
the BLA (see Figure 4). Utilizing microdialysis strategies, future studies could 
test how the Nf1+/- genotype affects the synaptic release of GABA in the BLA. 
Microdialysis could also be used to determine whether the co-deletion of Pak1 
restores GABA release in the BLA. Similarly, electrophysiological and 
microdialysis strategies could be further applied to these genetic intercrosses to 
analyze excitatory synaptic currents (EPSCs) in glutamatergic projection neurons 
in the BLA.  
Utilizing mass spectrometry, protein expression was characterized in the 
PFC and BLA. These results were independently analyzed and confirmed using 
SPSS statistical software (SPSS Incorporated, Chicago, IL). In total, twenty-one 
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proteins were identified in the PFC, and one protein was identified in the BLA. In 
the PFC, multiple proteins were identified that are associated with F-actin and 
microtubule dynamics. Future studies using immunohistochemistry could be used 
to better characterize neuronal morphology including the distribution and content 
of F-actin and microtubules in neurons in the PFC in each genetic intercross. 
Due to the role of MAPK and synapsin I in F-actin disassembly and vesicular 
release (Yamagata et al, 2002), microdialysis strategies could be used to 
measure vesicular release in neurons localized to the PFC. In addition, individual 
proteins of interest were identified in the PFC and BLA. For instance, LSAMP, 
STXBP1, and DREB play important roles in neurite formation and outgrowth 
(Pimenta and Levitt, 2004; Steiner et al, 2002; Geraldo et al, 2008), and THY1 is 
associated with social learning abnormalities in mice (Mayeux-Portas et al, 
2000). In the BLA, ADAM22 stabilizes the AMPAR/stargazing complex on the 
PSD-95 scaffolding platform, and thereby is involved in the regulation of AMPA 
receptors (Fukata et al, 2010). Following their confirmation using Western 
blotting, future studies could target each respective protein of interest using 
genetic and pharmacological manipulation in order to determine how each 
protein affects social learning in mice. 
In conclusion, this dissertation demonstrates a selective disruption in long-
term social learning / memory in Nf1+/- mice that is restored by the co-deletion of 
Pak1. The Pak1 co-deletion also restores the Nf1+/--related hyperactivation in 
MAPK and increases in IPSCs in the prefrontal-amygdala circuit, brain regions 
that have been implicated in social and emotional processes. Additionally, the 
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Nf1+/- mouse models show dysregulation in protein expression in the PFC and 
BLA that are restored by the co-deletion of Pak1 gene. This dissertation identifies 
dysfunction in F-actin and microtubule dynamics as well as several proteins of 
interest identified in the PFC (i.e., DREB, LSAMP, STXBP1, and THY1) and BLA 
(i.e, ADAM22). Together, these findings establish a role for Nf1 and Pak1 genes 
in the regulation of social learning in Nf1-deficient mice, and indicate that the 
pharmacological inhibition of PAK1 may represent a therapeutic target for the 
treatment of NF1-related social deficits in humans. However, future studies are 
necessary to clearly assess the predictive validity of Pak1 gene as a viable 
candidate for the treatment of NF1-related social deficits. 
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